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ABSTRACT 
We have used a subcellular spatial razor approach based on LC/MS-MS based proteomics 
with SILAC isotope labelling to determine changes in protein abundances in the nuclear and 
cytoplasmic compartments of human IMR90 fibroblasts subjected to mild oxidative stress. 
We show that response to mild tert-butyl hydrogen peroxide treatment includes redistribution 
between the nucleus and cytoplasm of numerous proteins not previously associated with 
oxidative stress. The 121 proteins with the most significant changes encompass proteins with 
known functions in a wide variety of subcellular locations (nucleus, mitochondria, 
endosomes, lysosomes, cytoplasmic vesicles, etc.) and of cellular functional processes 
(transcription, signal transduction, autophagy, iron metabolism, TCA cycle, ATP synthesis, 
etc.) and are consistent with functional networks that are spatially dispersed across the cell. 
Both nuclear respiratory factor 2 and the proline regulatory axis appear to contribute to the 
cellular metabolic response. Proteins involved in iron metabolism and/or with iron/heme as a 
cofactor as well as mitochondrial proteins are prominent in the response. Changes in 
subcellular distribution and in total abundance were not correlated and changes in 
compartmental abundance and/or subcellular redistribution rather than in total cellular 
abundance were the dominant feature for 84 of the 121 proteins. Evidence suggesting that 
both nuclear import/export and vesicle-mediated protein transport contribute to the cellular 
response was obtained. We suggest that measurements of global changes in total cellular 
protein abundances need to be complemented with measurements of the dynamic subcellular 
spatial redistribution of proteins to obtain comprehensive pictures of cellular function.  
KEYWORDS 
Quantitative Proteomics, Mass Spectrometry, SILAC, oxidative stress, tert-butyl hydrogen 
peroxide, DNA replication. 
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1. INTRODUCTION 
It has long been known that the oxidative state of cells contributes to various disease 
processes. There has been intense interest in recent years in the role of mitochondria and 
reactive oxygen species (ROS) in diverse diseases including diabetes, inflammatory diseases, 
neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease as well as 
cancer.1-5 Early efforts concentrated on protein damage caused by ROS and one branch of 
very active research has evolved towards protein damage processes and biological quality 
control mechanisms such as autophagy and mitophagy.6,7 In parallel it has become apparent 
that ROS are potent signalling systems under many physiological conditions.8,9 Much recent 
interest has centered on the intimate involvement of ROS in the special oxidative 
environment of mitochondria, where much of cellular ROS is generated10 and where 
mitochondrial proteins may show major dependence on ROS-related signalling, especially for 
cysteine-related systems.11 However, ROS are also generated at other locations, e.g. by the 
NOX family of proteins,12-16 and some aspects of ROS signalling may be locally spatially 
restricted. Spatial localization is also apparent in redox compartmentalization in eukaryotic 
cells, where different subcellular compartments are at different redox potential and different 
sets of proteins may be involved in control of ROS-related signaling.17,18  
At the same time, there is increasing evidence that the subcellular distribution of many 
proteins and, consequently the proteome of any given subcellular organelle, are both highly 
dynamic.19-23 Response to oxidative stress and ROS signalling is no exception. For example, 
NRF2 is dissociated from its cytoplasmic inhibitor KEAP1 and translocated to the nucleus in 
response to ROS-related signalling involving lipid peroxidation products,24-27 as well as 
phosphorylation signals.26,28 NRF2 controls expression of a wide variety of proteins related to 
oxidative stress29-31 and its activity as a transcription factor is dependent on the oxidation 
state of Cys residues.30,32,33  
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We have recently developed high-throughput proteomics subcellular spatial razor methods 
suitable for investigating dynamic aspects of protein subcellular distribution in the response 
of cells to stimulations.21,22 This approach, which combines global quantitative proteomics 
with the analysis of fractions enriched in target subcellular locations, has allowed 
measurement of the changes in total abundance and in the compartmental 
abundance/distribution between the nucleus and cytoplasm for several thousand proteins 
differentially expressed in IMR90 fibroblasts in response to mild tert-butyl peroxide (TBP) 
treatment. A highly selective subset of proteins shows appreciable response to TBP. We 
define a set of 121 proteins showing the most significant changes in total cellular abundance 
and/or in nuclear-cytoplasmic distribution and describe how these two mechanisms cooperate 
in achieving the changes in abundance in the nuclear and cytoplasmic compartments that are 
the basis of cellular response. Some of these proteins are involved in known ways with 
oxidative stress processes, but many are newly identified. Many proteins involved in iron 
homeostasis and/or with iron/heme as cofactors, as well as mitochondrial proteins and 
proteins involved in subcellular protein trafficking are prominent in the nuclear response to 
TBP. The large variety of functional processes in very diverse subcellular locations in which 
these proteins are implicated emphasizes the need for global, spatially resolved monitoring of 
coordinated cellular response to stress stimulations like exposure to TBP. 
2. MATERIAL AND METHODS 
2.1. Cell Culture and SILAC Labelling 
IMR-90 (ATCC CCL-186), a human diploid fibroblast adherent cell line, was obtained from 
LGC Standers (Middlesex, U.K) at population doubling (PD) 12. All experiments with 
IMR90 cells were done with a PD of less than 22 and tested for senescence using a 
readymade kit (KAA002) from Millipore Corporation (Billerica, MA, U.S). Cells were 
cultured under normal growth conditions at 37 ºC and 5% CO2 in SILAC-DMEM media 
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supplemented with 10% of SILAC dialyzed foetal bovine serum FBS. The SILAC kit 
(#89983) was used by following the manufacturer’s instructions (Thermo Scientific, 
UK).21,34,35 
For SILAC quantitative analysis, cells were divided into two populations and cultured in 
either light media containing amino acids 12C6, 
14N4-Arginine and 
12C6-lysine (Arg0, Lys0) or 
heavy media containing amino acids 13C6, 
15N4-Arginine (Arg10) and 
13C6-lysine (Lys6) by at 
least 7 passages in parallel in order to achieve a full incorporation of SILAC amino acids. 
The full incorporation of heavy isotope was checked by mass spectrometry of samples of 
lysed cells. 
2.2 Oxidative stress 
Mild oxidative stress was exerted upon IMR90 cells according to a published protocol36,37 
with minor modifications. Heavy cells were treated with 50μM tert-butyl hydrogen peroxide 
(TBP, SIGMA, Poole, UK) in cell culture media for 2h, while the light cells treated with 
50μM PBS were used as control. The treatment was stopped by replacing the cell culture 
media with fresh media without peroxide. On the next day, the heavy cells were again treated 
with TBP for 1h. Four hours after the removal of media containing peroxide, heavy or light 
cells were detached from the surface of tissue culture flasks by use of Trypsin-EDTA (Sigma, 
Gillingham, UK), washed 3x with PBS pH 7.4 and recovered by centrifugation at 60 x g. We 
collected and combined a total of 4 flasks each of heavy and light cells for sample 
preparation. 
2.3 Sample preparation 
Protein concentration was measured by using a Bio-Rad protein assay kit (Bio-Rad, Hemel 
Hempstead; UK). Heavy and light cells were mixed in a ratio of 1:1 based on protein 
concentrations and the amount of cell pellet.35,38 Cell lysis and subcellular fractionation were 
performed in order to obtain cytoplasmic (C, nuclear-depleted) and nuclear fractions (N). 
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Cells were lysed as described in Mulvey et al.34 in hypotonic buffer A containing 10mM 
HEPES pH 7.9, 10mM KCl, 0.1% Triton X-100, 2mM EDTA, 2mM DTT, 10% glycerol, 
0.34M sucrose and protease inhibitors (Roche Diagnostics, Burgess Hill, UK). After 10 min 
of lysis, the salt concentration and viscosity of the buffer was adjusted by addition of 100mM 
NaCl and 200mM sucrose (isotonic sucrose buffer B; IS buffer). Following a 5 min 
centrifugation at 2000 x g, the supernatant was collected as the crude cytoplasmic fraction. 
The nuclear fraction in the pellet was washed twice in IS buffer by an additional two 
centrifugation steps for 5 min at 2000 x g, with the washings restored to the crude 
cytoplasmic fraction. The crude cytoplasmic (nucleus-depleted) fraction was cleared by 
centrifugation at 13,000x g for 15 min and the supernatant used as the cytoplasmic fraction.  
The cytoplasmic fraction was concentrated using the Aston precipitation method by adding 
4:1 volumes of chilled acetone to the sample, which was kept overnight at -20 ºC. On the next 
day the sample was centrifuged and washed 3x with chilled acetone at 13,000x g  for 10 min 
at 4 ºC. The pellet was air dried for 5 min at room temperature to eliminate any acetone 
residue and then dissolved in modified RIPA buffer (50 mM Tris-HCl pH 7.4, 300 mM NaCl, 
1% sodium deoxycholate, 1% NP-40, 1 mM EDTA, 0.1% SDS and protease inhibitors).  
2.4 Protein Separation and In-Gel Digestion 
For each of the nuclear (N) and cytoplasmic (C) samples 60μg of total protein was separately 
resolved by 10% SDS-PAGE under reducing conditions. Proteins were visualized by silver 
staining with a ProteoSilver Plus kit (Sigma Aldrich, Poole, UK).39 At least 30 horizontal 
bands were excised from each gel lane and processed on a 96-well Progest plate (Digilab, 
Huntingdon, UK). Gel bands were processed with the Progest Investigator (Digilab, 
Huntingdon, UK) using established protocols for reduction and alkylation.40 Finally, gel 
plugs were rehydrated in 20μg/ml sequencing grade modified trypsin (trypsin-Gold) 
(Promega, Southampton, UK) that was prepared by adding (1:50 v/v) trypsin/25mM 
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ammonium bicarbonate, and incubated overnight at 37 °C. Fifty microliters of 0.1% formic 
acid was added in order to stop the tryptic digestion, the extracted tryptic peptides were 
collected in siliconized Eppendorf tubes (Sigma Aldrich, Poole, UK) and vacuum-dried to 
about 20μl, the volume adjusted to approximately 30μl with 0.1% formic acid, and the 
sample analysed by Orbitrap LC-MS/MS. 
2.5 Immunoblotting. 
Treated heavy (T) or untreated light cells (UT) were lysed in SDS-sample buffer for 3 min at 
90 ˚C and 60μg protein/lane resolved by 10-12% SDS-PAGE under reducing conditions. 
Proteins were transferred from gels onto Nitrocellulose membranes (Whatman Ltd, GE 
healthcare, Buckinghamshire, UK) by semi-dry electroblotting (15 V for 1hr). For oxidative 
stress markers, the membrane was blocked with 5% semi–fat milk powder TBS-Tween20 for 
1hr followed by 3x washing with TBST; the antibodies were blocked in 5% semi–fat milk 
powder TBS-Tween20 over night at 4 ˚C. The antibody concentrations were: 1:10000 of 
superoxide dismutase 1 SOD1 (ab79390), 1:1000 of Glutathione peroxidase 1 GPX1 
(ab108429) and 1:500 of catalase (ab76110), all from Abcam, Cambridge, UK. For the 
proteins Nrf2 and Keap, the membrane was blocked with 10% semi–fat milk powder PBS for 
1hr or overnight at 4 ˚C followed by 3X washing with PBS prior to the use of the antibodies. 
The antibody concentrations were: 1:300 Nrf2 (ab89443) and 1:500 Keap (ab66620) from 
Abcam, Cambridge, UK. 
The next day the membranes were washed 3-5x either with TBS-Tween20 or PBS for 10 min 
each and incubated for 1.5 hr at RT with the appropriate secondary antibodies dissolved in 
5% semi-fat milk powder TBS-Tween20 or 10% semi–fat milk powder PBS. Secondary 
antibodies were 1:2000 anti-rabbit IgG HRP-linked Antibody (7074S) from Cell Signalling, 
Hitchin, Hertfordshire, UK and 1:2500 Goat for anti-mouse IgG2a HRP-linked Antibody (ab 
97245) from Abcam, Cambridge, UK. Finally, the membranes were washed as described 
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above. However, the last washing step for TBS was without Tween20 to avoid interference 
with the ECL detection reagent. WB bands were visualised using ECL developing reagents 
(RPN2132) from GE Healthcare, Buckinghamshire, UK.  
2.6. Flow cytometry. 
Flow cytometry for cell cycle analysis followed the procedure described by Tudzarova et al., 
2010.36 Heavy and light cells were collected and fixed overnight at -20 ºC in 80% methanol in 
PBS. Cells were precipitated by centrifugation at 50 x g for 10 min, the supernatant discarded 
and the cells suspended in a Propidium Iodide master mix in PBS containing 50μg/ml RNase 
A, 50μg/ml Propidium iodide solution (Sigma Aldrich, Poole, UK) and protease inhibitors 
(Roche Diagnostics, Burgess Hill, UK) with a final cell density of 1x106 cells/ml. Cells were 
incubated at 37 ºC for 30 min in darkness. Cells were sorted by use of a DAKO/Beckman 
Coulter MoFlo High speed sorter (Beckman Coulter Inc., Orange County, CA). The forward 
scatter signal was used for detection of cells and the propidium iodide signal fluorescence 
was linearly quantified to rationalize DNA content after excitation at 488 nm in the 
orange/red channel (613/20 nm bandpass filter).36 
2.7 Immunofluorescence and Confocal microscopy 
To demonstrate that nuclei and mitochondria remained structurally intact before and after 
oxidative stress, immunofluorescence and confocal microscopy were used. The IMR90 cells 
were grown in glass bottom Petri dishes (12 mm, 1.5 thickness, GWSt-3512; WillCo Wells 
B.V., The Netherlands). Control and TBP-treated IMR90 cells were washed 3x with PBS+ 
containing 1mM CaCl2 and 0.5mM MgCl2. Mitochondria were stained with 100nM of 
MitoTracker green M-7514 or 200nM MitoTracker deep red FM (Life Technologies Ltd, 
Paisley, UK) in the cell culture growth medium for 30 min at 37 ºC, followed by two washes 
for 5 min with medium at normal growth condition. Nuclear staining was performed by 
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adding 1.5 drops of Hoechst 33342-Readymade R37605 (Life Technologies Ltd, Paisley, 
U.K) to the medium for 15 min in the dark at room temperature.  
Alternatively, prior to imunocytochemistry, cells were stained with 200nM MitoTracker deep 
red FM as before, directly fixed and permeabilized for 5 min at -20oC with ice-cold 1:1 
methanol-acetone; and washed 3X with PBS for 2-5 min each. Primary antibodies for 
ALDH18A1 (#HPA008333) from Atlas antibodies, Sigma, Gillingham, UK and ATP5A1 
(#PA5-27504) from Thermo Fisher Scientific Inc.; Rockford, IL USA were respectively 
diluted 1:50 and 1:25 in 4% PBS/FBS and incubated with the fixed cells at 4 ºC overnight. 
Cells were subsequently washed 4X for 10 min with PBS and incubated for 1.5hr in the dark 
with 1:1000 fluorescent secondary FITC antibody (#F0382) from Sigma, Gillingham, UK 
diluted in 4% FBS/PBS. Nuclei were stained and cells were covered with VECTASHIELD 
mounting media with DAPI (#H-1200) from Vector Laboratories Ltd., Peterborough, UK. 
Image acquisition was performed with a Perkin Elmer spinning-disk confocal laser 
microscope (PerkinElmer, Cambridge, UK) and a 63×/1.4 numerical aperture oil immersion 
lens. The excitation maximum (nm) and emission maximum (nm) was the following: for 
DAPI, 358 and 461; for Hoechst 3342, 352 and 461; for Mitotracker Green FM, 490 and 516; 
for Mitotracker Deep red FM, 644 and 665; for FITC, 490 and 525 respectively. 3D images 
were taken with technical assistance from Mr. Thomas Adejumo (Wolfson Institute for 
Biomedical Research and the UCL Cancer Institute, UCL, London, UK). 
2.8 Mass spectrometry 
LC-MS/MS analysis was performed on a classic LTQ-Orbitrap (Thermo Fisher Scientific, 
UK) equipped with a SURVEYOR-MS pump and Thermo Micro AS-autosampler. Peptides 
were resolved or loaded using a fused silica capillary column (Nikkyo Technos Co., Japan), 
which is a part of the nanoelectrospray ion source with an initial desalting step using a 
MiChrom C18 Captrap for peptides. Liquid chromatography was carried out at ambient 
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temperature at a flow rate of 500nl/min using a dual gradient of Buffer A: 0.1% formic acid; 
and Buffer B: 100% acetonitrile (ACN) with 0.1% formic acid. Separation was achieved by a 
5-23% buffer B gradient (95-77% Buffer A) for 65 min, followed by 23-40% Buffer B (77- 
60% Buffer A) gradient for 30 min, and a step gradient to 60% Buffer B for 5 min. Full 
Profile data was acquired on the LTQ-Orbitrap. 
The measurements were done under positive ion mode. The tuning parameters were as 
follows: spray voltage 1.40kV, a capillary temperature of 200°C. A full scan was collected 
for eluted peptides in the range 450-1600 m/z with the Orbitrap portion of the instrument at a 
resolution of 60,000, followed by MS/MS using CID (Collision Induced Dissociation) with 
dynamic exclusion of 40s and a maximum number in the dynamic exclusion list of 500 in the 
LTQ portion of the instrument with a minimum count threshold of 500. An activation q value 
of 0.25 and activation time of 30ms was applied for MS2 acquisitions. XCalibur software 
version 2.0.7 (Thermo Fisher Scientific, U.K.) was used for data acquisition.34 Homo sapiens 
species restriction with the number of protein entries searched: 218,357. 
2.9 Data analysis, protein identification and quantification 
Raw MS files from all replicate SILAC experiments were uploaded into the MaxQuant 
software platform (version 1.3.0.3) for peak list generation, quantification of SILAC pairs, 
identification of individual peptides, protein identification and assembly into protein groups. 
XCalibur raw files were processed and searched against a UniProt fasta 
(ftp://ftp.uniprot.org/pub/databases/uniprot/current_release/knowledgebase/proteomes/) 
human protein database (downloaded 5/10/2012). Selected MaxQuant analysis parameters 
included trypsin enzyme specificity, SILAC doublet measurements of Lys6 and Arg10, 2 
missed cleavages, minimum peptide length of 7 amino acids, minimum of 2 peptides (1 of 
which is unique), top 6 MS/MS peaks per 100 Da, peptide mass tolerance of 10 ppm for 
precursor ions, and MS/MS tolerance of 0.5 Da. Oxidation of methionine and N-terminal 
 11 
protein acetylation were selected as variable modifications, and cysteine 
carbamidomethylation was selected as a fixed modification. All proteins were filtered 
according to a false discovery rate (FDR) of 1% applied at both peptide and protein levels. 
Proteins were automatically quantified by the MaxQuant software: a minimum of 2 peptide 
ratio counts from razor and unique peptides were necessary for protein quantification, and the 
“requantification” option was enabled. An Experimental Design template was used to specify 
individual experiments and reverse labeling conditions within the analysis. The final Protein 
Groups and peptides text files were processed with Perseus (versions 1.3.0.4). Peptides with a 
normalized Significance B score of p < 0.05 were included for downstream analysis.34,41,42  
2.10 Correlation of Proteins across Different Samples 
The MaxQuant software package41,42 was used to identify proteins for 12 data analysis sets: 
(a) each nucleus (N) sample replicate and the union of the three N samples, (b) each 
cytoplasm (C) sample replicate and the union of the three C samples, (c) each C&N replicate 
and the union of the three C&N samples. C&N denotes that for each individual biological 
replicate, the MS data for the C and N samples were jointly processed with MaxQuant to 
estimate changes in total protein abundance. For this data, a correction for enrichment of 
nuclear proteins in the MS data analyses was applied during estimation of total protein 
abundance (See Supplementary Text). Across these samples, a total of 4429 protein sequence 
groups were found. For the same underlying gene, slightly different protein sequence groups 
were sometimes observed depending on the exact set of peptides detected in each sample. 
Using the principle that sequence groups in different samples that correspond to the same 
underlying protein(s) must have protein sequences in common, the union of the unique 
peptides for protein sequence groups with shared protein sequences was formed and used to 
re-query the full UniProt human sequence data set to identify “consensus” sequence groups 
across the three sample types. This gave 3589 independent proteins (sequence groups) for 
which the MS data, including the individual replicates, is given in Supplementary Table S1. 
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All of the consensus sequence groups contained at least one consensus protein sequence that 
contained all unique peptides in the group and all were independent, i.e. there were no protein 
sequences shared between different consensus protein sequence groups.  
2.11 Selection of Significantly Changed Proteins 
To select a set of proteins showing the most significant changes in SILAC ratios for the 
oxidative stress experiments we used the MaxQuant Significance B score41 (SigB hereafter) 
and procedures analogous to those applied previously for cell cycle arrest.21,34 A minimum of 
at least 3 ratio counts were required for inclusion of a SILAC ratio in the selection 
procedures. For SILAC ratios measuring changes in the nuclear (Sn), cytoplasmic (Sc) and 
total (St) abundances, we used the cutoff limits SigB
union < 0.002 and SigBreplicate < 0.006, 
where SigBunion refers to the union over the three replicates (e.g. the 3 nuclear replicates) and 
SigBreplicate refers to the individual replicates (e.g. each nuclear replicate). Proteins showing 
the most significant changes in Sn, Sc and St were selected with the joint requirement SigB
union 
< 0.002 and SigBreplicate < 0.006 for at least two replicates. For the redistribution parameter 
Sn/Sc, which detects nucleus-cytoplasmic redistribution even in the absence of changes in 
total protein abundance21,22 (see Supplementary Text), we used the joint limits 
|log2(Sn/Sc)|
union > 0.9 (0.54 > Sn/Sc > 1.87) and |log2(Sn/Sc)|
replicate > 0.8 for at least two 
replicates. This led to selection of 121 proteins (the 121-OxS set, see text) for subsequent 
network analyses. A summary for these proteins and the selection procedures is given in 
Supplementary Table S2. As described previously,21 the concomitant use of limits on the 
union and on individual replicates tended to select proteins with substantial numbers of ratio 
counts, i.e., a minimum of 9 ratio counts (in a single sample) and a median of 120 ratio 
counts per protein were used in classifying the proteins in the 121-OxS set. 
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2.12. Bioinformatics Analysis of Functional Networks 
For the identification of functional annotations, associations, interactions and networks 
within our dataset, a combination of several data analysis tools was used. The consensus 
Gene Name identifiers for the 121-Oxs set of most significantly changed proteins were 
uploaded into STRING version 9.1 (Search Tool for the Retrieval of Interacting 
Genes/Proteins), to create a protein interaction network based on known and predicted 
protein-protein interactions.43,44 A threshold confidence score of 0.7 was used to ensure that 
only highly confident protein interactions were considered for inclusion in the network. 
Seven types of protein interaction information were used for network generation, including 
neighbourhood, gene fusion, co-occurrence, co-expression, experimental, database 
knowledge and text mining. Three networks from STRING were further analysed: the 121-
OxS set, a 240-OxS set containing an additional 119 “white nodes” densely connected to 
121-OxS that were suggested by STRING, and a 173-OxS set containing the 121-Oxs set and 
52 of the 119 “white nodes” quantified in our experiments, but not amongst the proteins 
showing the most significant changes (see text). Densely connected clusters in these networks 
were identified with MCODE 1.32.45 BiNGO 2.44 46 was used to obtain enriched GO BP 
(biological process) terms. DAVID 47 was used to scan for other types of annotations. The 
combined STRING, BINGO and DAVID results were used to select a set of 32 GO 
biological process terms to describe the cellular response (see text, Table 2, Supplementary 
Table S3). These terms corresponded to groups of proteins with enriched GO BP terms, but 
we also included additional terns to cover other proteins selected as significant in the 121-
OxS set (Supplementary Table S3). The networks were imported into Cytoscape version 
2.8.2 for further analysis and visualisation.48,49 Other groups of proteins, e.g., proteins 
annotated to glycolysis (see text), were selected for comparison using the QuickGO50 facility 
at the European Bioinformatics Institute (http://www.ebi.ac.uk/QuickGO/) with appropriate 
sets of GO identifiers.  
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3. RESULTS 
The proteomics subcellular spatial razor experiments described in the following are based on 
a model which envisages that in response to a cellular perturbation, proteins may show both 
changes in total cellular abundance and in their subcellular spatial distribution between the 
nucleus and cytoplasm.21,22 To apply the model, experimental measurements of protein 
abundance ratios (SILAC ratios) between stimulated/unstimulated cells are obtained for three 
data sets: (1) a nucleus-enriched sample obtained by subcellular fractionation (N), (2) the 
corresponding nucleus-depleted sample (C), which we refer to as the “cytoplasm” in the 
following text, and (3) a total protein sample (T). The corresponding SILAC ratios provide 
measures for each protein of the overall change in total cellular abundance (St), or of the 
localized change in abundance in the nuclear (Sn) or cytoplasmic (Sc) subcellular 
compartments. A mathematical formulation of the model is given in the Supplementary Text. 
Stringent purification of organelles (e.g., nucleus) was not attempted in this study as we 
believe it is not feasible to purify to homogeneity organelles that are subject to dynamic 
changes in their protein content and that unnecessary protein loss is incurred during such 
organelle isolation methods. We preferred to use highly enriched fractions rather than highly 
purified organelles. This approach has previously been shown to successfully detect nucleo-
cytoplasmic trafficking.21,22 
We rigorously validated and checked the oxidative stress response for the IMR90 cells (a 
human diploid fibroblast adherent cell line) by the use of complementary cell biology and 
proteomics methods. Oxidative stress was generated by the use of tert-butyl hydrogen 
peroxide (TBP, see Materials and Methods). Cellular response to oxidative stress was 
monitored by flow cytometry to determine cell cycle profiles, inspection of cell viability by 
light microscopy, and western blotting of oxidative stress markers. Optimal dosage with TBP 
for the IMR-90 cells was determined with these methods.  
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Response of the cells to oxidative stress was demonstrated by Western blotting. As 
expected,29 the oxidative stress regulated protein NRF2 increased in abundance and 
accumulated in the nucleus whereas its 
inhibitor KEAP1 was detected only in the 
cytoplasm and decreased in abundance (Fig. 
1A).  
Flow cytometry analysis of DNA content 
(Fig. 1B) shows that mild THP oxidative 
stress led to an accumulation of IMR90 cells 
at G2/M and in G1, with a concomitant 
decrease in the proportion of cells in S 
phase, indicative of checkpoint activation and cell cycle arrest. The lack of cell counts in the 
sub-G1 region together with a microscopically determined high degree of cell viability 
indicates that the IMR90 cells did not induce apoptosis in response to mild oxidative stress. 
The subcellular fractionation protocols were optimized using the nuclear and cytosolic 
markers lamin and tubulin respectively (data not shown). We adapted a published procedure 
using the nuclear protein Lamin A/C (ref) to test for nuclear leakage during fractionation. In 
the samples used for the quantitative analyses described below, the recorded 
cytoplasm/nucleus MS intensity ratio for Lamin A/C ranged over 0.2 to 0.8% for the three 
replicates, i.e. for IMR90 cells with our protocols any nuclear leakage during fractionation 
was minimal and did not materially affect the measured SILAC ratios (1.185 ≤ Sn ≤ 1.197, 
0.964 ≤ Sc ≤ 1.009 for Lamin A/C over the three replicates). The reproducibility of the 
preparations was tested by correlation of the SILAC ratios Sn, Sc and St between the three 
replicates for each sample type. High correlation (0.75 < R2 < 0.88), with most variance 
concentrated in a handful of readily recognizable outliers with few SILAC counts 
(Supplementary Figure S1), provided confirmation of highly reproducible sample 
Figure 1. Characterization of the cellular response to oxidative 
stress and the subcellular fractionation. (A) Western blotting of 
NRF2 and KEAP1 of the nuclear (N) and cytoplasmic (C) 
fractions for untreated (U) or TBP-treated (Ox) cells showing 
cellular response to oxidative stress. (B) FACS determination of 
the cellular distribution over the cell cycle.  
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preparation. The purity of the nuclear and cytoplasmic fractions was evaluated from the MS 
data (see section B below). 
3.1. Characterization of the MS data 
The MaxQuant software package41,42 was used to identify proteins and determine SILAC 
ratios for 12 data sets: (1) each nucleus (N) sample replicate and the union of the three N 
samples, (2) each cytoplasm (C) sample replicate and the union of the three C samples, and 
(3) each C&N replicate and the union of the three C&N samples. C&N denotes that for each 
individual replicate the MS data for the C and N samples were jointly processed with 
MaxQuant to estimate changes in total protein abundance (T) (see Methods and 
Supplementary Text). Correlation of these sequence groups across the samples (see Methods) 
gave the 3589 independent proteins (sequence groups) for which the full MS data, including 
the individual replicates, is given in Supplementary Table S1. A total of 1929 C proteins and 
2751 N proteins were detected. Their distribution over the nucleus and cytoplasm is shown in 
Fig. 2: 783 proteins were detected only in the cytoplasm, 1605 proteins only in the nucleus 
and 1146 were detected in both locations. A further 35 
proteins were detected only in the jointly processed 
C&N data set. Amongst the 783 C and 1605 N 
proteins, there were many with large numbers of 
sequenced peptides/ratio counts, which further 
confirmed that the subcellular fractionation was 
efficient and that there are many proteins characteristic of one or the other location. With the 
requirement of at least 2 peptides (1 unique) and 3 ratio counts in a single sample, SILAC 
ratios were obtained for 1623 cytoplasmic proteins (Sc), 2451 nuclear proteins (Sn) and 3124 
total proteins (St). For 973 proteins, SILAC ratios (Sc, Sn, St) were obtained for all three data 
types.  
Fig. 2. Distribution over the nucleus (N) and 
cytoplasm (C) for all identified proteins  
(detected) or for the set of proteins (121-OxS 
set) selected as showing the most significant 
changes in compartmentalized abundance (Sc, 
Sn), total abundance (St) or distribution between 
the nucleus and cytoplasm (Sn/Sc). 
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MaxQuant normalizes protein ratios for each data set and employs an algorithm within the 
Perseus program to calculate an outlier probability score (Significance B score, hereafter 
SigB) in order to find the most significantly altered proteins.41,42 SigB was calculated for the 
proteins in each of the 12 data sets using the MaxQuant quantitative analysis suite. These 
SigB values and the parameter log2(Sn/Sc), which detects redistribution between C and N even 
in the absence of total abundance changes21,22 (see Supplementary Text), were used to select 
121 proteins (3.4% of all identified proteins, referred to as the 121-OxS set hereafter) that 
showed the strongest, reproducible changes in compartmental abundance (Sn and/or Sc), in 
total abundance (St), and/or in redistribution between the cytoplasm and nucleus (Sn/Sc) in 
response to oxidative stress. The inclusion of reproducibility over the replicates in the 
selection criteria (see Material and Methods) meant that the selection of significant proteins 
was stringent and tended to reject proteins with few ratio counts: a minimum of 9 ratio counts 
(in a single sample type) and a median of 120 ratio counts per protein were used in 
classifying the proteins in the 121-OxS set. For the data sets in which they were quantified, 
Fig. 2 shows the distribution of the proteins in the 121-OxS set over the cytoplasm and 
nucleus. Supplementary Table S2 contains a summary of the SILAC ratios Sc, Sn, St and Sn/Sc 
for these proteins. Overall the number of significant changes for the 121-OxS set included 19 
proteins (Sc), 63 proteins (Sn), 76 proteins (St) and 43 proteins (Sn/Sc), that is, some proteins 
satisfied more than one selection criterion.  
3.2. Consistency of the data with high enrichment of the nucleus sample  
There is increasing evidence that many proteins have multiple subcellular locations and may 
have different functions in different locations (see Discussion). In keeping with this, many of 
the proteins that were quantified in the nucleus have GO CC (cellular component) 
annotations to other subcellular locations. For example, in the N sample we quantified 371 
proteins with annotation to mitochondria, of which 147 were also annotated to the nucleus. 
There were also many proteins with annotations to other subcellular sites in the nuclear 
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fraction (Fig. 3, table inset). To further verify that the 121-OxS set of proteins was not 
distorted by cross contamination of the nuclear fraction with other subcellular organelles, we 
looked at the distribution of the function Sn/St = fs/fu, where fs and fu are the fractions of a 
protein in the nucleus in stimulated or unstimulated cells respectively (see Supplementary 
Text). The vast majority of the proteins with annotation to mitochondria had fs/fu ~ 1, that is, 
there was no appreciable change in their nuclear fraction in response to oxidative stress (Fig. 
3A). A small number of proteins exhibited appreciable changes in fs/fu, including proteins 
such as HK151 and BAX52-54 that are known to show increases in nuclear abundance that are 
associated with important functional roles in response to oxidative stress. In agreement with 
previous studies, changes in total abundance 
for both of these proteins were small (St = 
1.14/1.04 for HK1/BAX), i.e. the dominant 
change was in subcellular location. Similar 
plots were obtained for proteins with GO 
annotations to plasma membrane, 
endoplasmic reticulum, Golgi apparatus, 
endosomes, lysosomes and peroxisomes 
(Supplementary Figure S2). In all cases 
there were both increases and decreases in 
fs/fu involving a small percentage of the 
proteins (Fig. 3 table). This pattern indicates 
that those proteins with appreciable changes 
in fs/fu are not a consequence of 
contamination of the nuclear fraction with 
other subcellular organelles. This conclusion 
is further stressed by looking at high 
Figure 3. Analysis of the enrichment/purity of the 
nuclear fraction. Table. The number of quantified 
proteins in the nuclear fraction that are annotated to 
other subcellular locations and the number showing 
appreciable change in their nuclear fraction (Sn/St = 
fs/fu.) (A) left: log2(fs/fu) as a function of the average 
number of ratio counts over the nucleus and total 
data sets for proteins with GO annotation to 
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abundance proteins that are present in multiple subcellular locations. There were many high 
abundance proteins annotated to mitochondria that showed no change in fs/fu, e.g., PHB in 
Fig. 3A. The same phenomenon was observed for numerous high abundance proteins 
annotated to other subcellular locations (Supplementary Figure S2). For example, log2(fs/fu) = 
0.009 for prohibitin (PHB) (Fig. 3B), which is annotated to diverse functions including cell 
proliferation, differentiation and apoptosis.55-58 It has known functions in the nucleus,59 
mitochondria60 and plasma membrane.61,62 Large numbers of high abundance proteins that 
show essentially no change in measured fs/fu, such as the examples in Fig. 3B, are consistent 
both with high reproducibility of the subcellular fractionation and with very little cross 
contamination of the nuclear fraction by other subcellular organelles, as has been observed 
for other cell types with other forms of analysis.23 Overall these data patterns are very strong 
evidence that oxidative stress causes selective changes in nuclear abundance for a set of 
specific proteins. The data also suggests that current GO annotations underestimate the 
proportion of proteins that are shared between the nucleus and other subcellular locations 
such as mitochondria, a characteristic that we have also observed for other cell types.22,23,63  
3.3. Correlation of Changes in Abundance and Nucleus/Cytoplasmic Distribution 
Because the abundance of a protein in the nucleus/cytoplasm can be altered by changes both 
in total cellular protein abundance and in distribution between the two compartments, the 
SILAC ratios Sn and Sc do not directly measure redistribution of a protein between the two 
compartments. A direct measure for redistribution to/from the nucleus that is independent of 
changes in total protein abundance is provided by Sn/Sc = fs(1-fu)/fu(1-fs) (see Supplementary 
Text). We used the 87 proteins with the most significant changes that were quantized in both 
the nucleus and cytoplasm to test for correlation between changes in total abundance (St) and 
changes in nucleus-cytoplasm distribution (Sn/Sc). There was very little correlation (Fig. 4A), 
that is, the changes in abundance in the nuclear and/or cytoplasmic compartments do not 
simply mirror changes in total protein abundance. We further characterized the response to 
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oxidative stress of these 87 proteins using the orthogonal 3D basis set {Sn/St, Sc/St, St} (Fig. 
4B, C). This “subcellular spatial razor” basis set expresses changes in the total abundance of 
proteins along a St axis and changes in their N/C distribution in a {Sn/St, Sc/St} distribution 
plane that is independent of changes in total abundance.21,22 Conservation of mass requires 
that in the distribution plane the data points appear in two allowed quadrants corresponding 
to N → C and C → N redistribution respectively (Fig. 4, see also Supplementary Text).  
The 3D subcellular spatial razor format is sensitive to changes in total protein abundance, to 
redistribution of proteins between the nucleus and cytoplasm, and also to the basal 
nuclear/cytoplasm distribution of proteins in unstimulated cells. For example, for the 121-
OxS set of proteins, classic oxidative stress response proteins such as the light and heavy 
subunits of ferritin (FTL, FTH1) showed substantial increases in total abundance, but little or 
no C  N redistribution (Fig. 4C). In contrast, eight subunits of the CCT protein-folding 
complex showed little or no change in total abundance, but substantial C → N redistribution, 
while proliferating cell nuclear antigen (PCNA) showed N  C redistribution with little 
change in total abundance. PCNA and the CCT proteins show log2(Sc/St) ~ 0 that reflects 
basal abundance strongly skewed to the cytoplasm. The small proportion of the protein in the 
nucleus is increased (CCT) or expelled to the cytoplasm (PCNA) under oxidative stress. Such 
behavior might reflect “catalytic” transfer of information about oxidative stress between 
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Fig. 4. Subcellular characterization of the 87 proteins of the 121-OxS set for which Sn, Sc and St were all measured. 
(A) Plot of changes in nuclear-cytoplasmic distribution (Sn/Sc) versus changes in total abundance (St). The red 
bounding box corresponds to 1.5-fold changes in total abundance and 0.57 > Sn/Sc > 1.74 (|log2(Sn/Sc)| > 0.9). A few 
proteins appear just inside the bounds because the combinations of basal distribution, changes in total abundance 
and changes in distribution can lead to individual compartmental abundances (Sn or Sc) being selected as 
significant. (B) 3D spatial razor plot for the 87 proteins. The dotted green lines correspond to the bound |log2(Sn/Sc)| 
= 0.8. (C) Same as panel B for selected, labelled proteins or protein complexes (see text). In (B,C), changes in total 
abundance (perpendicular to the page) are color coded according to the scale at the right. 
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different subcellular locations. Proteins such as Nucleoside diphosphate kinase A (NME1) 
have less strong basal skewing of abundance, show appreciable, coupled changes in 
abundance in both subcellular compartments in response to oxidative stress and might 
represent more general “balancing” of function between different subcellular locations. Other 
protein groups appear to show some coupling between total abundance and subcellular 
distribution. For example, six subunits of ATP synthase (ATP5) show ca. 2-fold decreases in 
total abundance accompanied by N → C redistribution, that is, reduced total abundance was 
accompanied by further depletion of these proteins in the nucleus. Conversely, eight subunits 
of V-type proton ATPase (ATP6) show about 1.8-fold increase in total abundance 
accompanied by a trend of C → N redistribution. 
The data for Sn, Sc, St and Sn/Sc for all 
proteins in the 121-OxS set is summarized 
in Supplementary Table S2. Figure 5 shows 
a visual representation of the significant 
changes in Sc, Sn and Sn/Sc for the proteins 
in the 121-OxS set measured in both 
compartments. A general characteristic of 
many of the proteins is that they participate 
in many different functional processes as 
these are currently defined by GO ontology 
terms (see below). For example, proteins 
annotated to cell differentiation include 
proteins also annotated to ATP synthesis, 
lipid metabolism, heme/iron metabolism, 
cell adhesion, negative regulation of apoptosis and protein transport.  
Figure 5.  Visual summary of the most significant changes in 
subcellular abundance and nucleo-cytoplasmic distribution for 
the proteins of the 121-OxS set quantified in both the nuclear 
and cytoplasmic compartments. A selection of some of the GO 
biological process terms annotated to the proteins (see text) is 
indicated. 
 22 
We used fluorescence imaging to verify several aspects of the MS analyses of the response to 
oxidative stress. Firstly, imaging of mitochondria and the nucleus indicated structural 
integrity with no apparent nuclear breakage or major alteration of the mitochondria 
(Supplementary Figure S3). This is in keeping with mild oxidative perturbation and no 
apparent increase in apoptotic cells detected by flow cytometry or light microscopy. Second, 
proteins such as the subunits of ATP synthase (ATP5) are well known as part of the 
mitochondrial respiratory chain, but have not been regarded traditionally as nuclear proteins 
and we therefore investigated the presence of ATP5A1 in the nucleus of intact IMR90 cells. 
In both control cells and cells subjected to oxidative stress, ATP5A1 was widely distributed 
over mitochondria, nuclei and generally over the cytoplasm (Supplementary Figure S3). This 
is consistent with previous studies indicating that subunits of ATP synthase can be distributed 
to many subcellular locations and may have different functions at those locations.64-67 At 
present GO CC annotations for ATP5A1 include mitochondria, nucleus, plasma membrane 
and the extracellular region. Third, we also investigated the presence in the nucleus of Delta-
1-pyrroline-5-carboxylate synthase (ALDH18A1), a constituent of the proline regulatory axis 
(see below), which showed >2-fold reduction in nuclear abundance for OxS (Supplementary 
Table S2). Although this protein seems to preferentially redistribute from the cytoplasm to 
mitochondria under oxidative stress, there are focal points of the protein in the nucleus for 
both control and oxidatively stressed cells (Supplementary Figure S3). It is currently 
annotated to the cytoplasm and mitochondria by GO. 
Extensive dispersion of the proteins in the 121-OxS set over many subcellular locations is 
also evident in the current GO CC annotations for these proteins. Table 1 shows the number 
of annotations to four main top-level locations (nucleus, cytoplasm, plasma membrane, 
extracellular region) with a further breakdown of cytoplasmic locations. With the vocabulary 
shown in Table 1, 117 of the proteins had annotations. There was an average of 2.99 
locations per protein and a maximum of 8 locations per protein. The 45 proteins annotated to 
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the nucleus included annotations to the cytoplasm (31 proteins), the extracellular region (18 
proteins) and the plasma membrane (9 proteins). Similarly, amongst the 64 proteins 
annotated to the cytoplasm, 31, 20, 37 were annotated to the nucleus, plasma membrane and 
extracellular region respectively. The proteins are also annotated to a variety of different 
cytoplasmic locations. For example, proteins 
annotated to the nucleus include annotations 
to all of the cytoplasmic locations shown 
except the peroxisome. Conversely, we 
quantified 10 proteins in the nucleus and 
cytoplasm that were only annotated to 
nucleus and 33 proteins in the nucleus and 
cytoplasm that were only annotated to cytoplasm. This suggests that the current GO CC 
annotations underestimate the dispersion of proteins over multiple subcellular locations. This 
is a characteristic that we have also observed with other cell types.22,23,63 
3.4. Functional Network Analyses.  
To further analyze the functional significance of the changes for proteins corresponding to 
the 121-OxS set, we used the STRING programs43 to look for functional networks, which 
were visualized with Cytoscape68 (see Methods). Interaction networks were obtained for 
three sets of proteins: (1) the 121-OxS set; (2) a 240-OxS set consisting of the 121-OxS set 
plus 119 “white nodes” suggested by STRING that correspond to other proteins that have the 
most dense interactions with the proteins in the 121-OxS set; and, (3) a 173-OxS set 
consisting of the 121-OxS set plus the 52 additional “white node” proteins suggested by 
STRING and quantified in our experiments. Of the 119 white nodes suggested by STRING, 
52 were in fact quantified in the MS data, but were not amongst the 121-OxS set of proteins 
selected as showing the most significant changes in response to oxidative stress. With these 
three data sets, the MCODE clustering algorithm was used to identify clusters of nodes with 
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dense interactions. GO BP (biological process) enrichments calculated with BiNGO 46 and 
other annotation identified with DAVID 47 were used to identify functions associated with 
these clusters (Table 2). The 240-OxS set defines the most likely main functional processes, 
the 173-OxS set provides a measure of how well these processes were monitored in our 
measurements and the 121-OxS set provides a “pure” probability that may be small if only a 
few proteins in the network change.  
Fig. 6A provides a graphical overview of the STRING results and indicates that different 
behavior in response to oxidative stress is observed for different groups of proteins. For 
example, most of the subunits of ATP synthase (ATP5) were monitored (Table 2) and 
showed similar behavior (decrease in St with N  C redistribution). For V-type proton 
ATPase (ATP6) many subunits were monitored (Table 2), but showed inverse behavior 
(increase in St with C  N redistribution). In the full MS data set 47 proteins that are 
included in proteasomal complexes were quantified. The 240-OxS network includes 16 
proteasomal proteins, 14 of which were quantified, but only PSMD-5,6,11 (increased St and 
C  N redistribution) were in the 121-OxS set with the most significant changes. All of these 
three are annotated to GO:0071158, “positive regulation of cell cycle arrest”. From the  
nuclear COPS signalosome complex 9 proteins were quantified and are included in the 240-
OxS network, but only COPS3, ATP5A169 and HSP1A1 were included amongst the proteins 
of the 121-OxS set with the most significant changes and COPS3/HSP1A1 showed different 
behavior than ATP5A1. Conversely, all 8 proteins of the CCT complex involved in de novo 
post-translational protein folding (Table 2) were included in the 121-OxS set (St ~ 1, C  N 
redistribution). There have long been indications of connections between oxidative status and 
the cell cycle and Fig. 6A contains densely linked clusters for proteins (DNA polymerase 
delta subunits, replication factor C subunits) intimately linked to DNA replication (see 
Discussion). 
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Despite these clear clusters of proteins associated with specific cellular functions, a striking 
feature of Fig. 6A is that many classical oxidative stress proteins such as FTL, FTH1, 
HMOX1 were only weakly connected by STRING and 35 proteins were unconnected. In part 
this seems to reflect incomplete inclusion of literature information in the STRING interaction 
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database. For example, for POLDIP2 (unconnected) and PGRMC1 (unconnected) there is a 
substantial literature about their functional roles (see Discussion), but the interactions are not 
included in the STRING database. This is not a drawback of the STRING programs 
specifically. Similarly disconnected (in different ways) networks were also observed with 
Figure 6. Network analysis for the 240-OxS and 121-OxS data sets. (A) STRING interaction network for the 240-OxS set. Nodes 
corresponding to the 121-OxS set are colored in red, nodes suggested by STRING and quantified in the MS data, but not included in 
the 121-OxS set are colored in yellow and nodes suggested by STRING but not quantified in the MS data are colored in grey. Node 
sizes are mapped to the Betweenness Centrality values, while edge colours and sizes are mapped to Edge Betweenness values, as 
calculated by the Network Analysis plugin for the Cytoscape software. Betweenness centrality is a measure of a node's centrality and 
importance in a network. EdgeBetweenness is a topological measure defined as a normalized number of shortest paths between two 
nodes. (B) Thumbnails of the interaction network: nodes colored in blue indicate significant changes in Sn, Sc, St and/or Sn/Sc of 
proteins that are included in the 121-OxS set. 
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preliminary GeneMania calculations and probably reflect that interaction databases presently 
tend to be dominated by large-scale co-expression and physical interaction data sets.  
There is another striking feature of the data that is summarized visually by Fig. 6B. A protein 
may have the same or different functions in the nucleus or in the cytoplasm, but the 
contribution of the function(s) to cellular response should in both cases be dependent on its 
dynamic abundance in the subcellular location, as reflected in Sn and Sc. Changes in total 
abundance (St) and in nucleus/cytoplasm distribution (Sn/Sc) represent the mechanisms by 
which the changes in compartmental abundance are achieved. For the 121-OxS set, only 76 
of the proteins were selected for inclusion on the basis of changes in total abundance and for 
39 of these proteins SigB was smaller for changes in Sn or Sc than for St, i.e., for these 39 
proteins compartmental changes in abundance were more significant than changes in total 
abundance as a consequence of concomitant changes in total abundance and redistribution.  
Conversely, for the 45 proteins for which St was not selected as being among the most 
significant features, 26 proteins had their most significant changes in the cytoplasmic (9 
proteins) or in the nuclear (17 proteins) compartments as a consequence of concomitant 
changes in total abundance and redistribution. For 19 proteins, the redistribution parameter 
(Sn/Sc) was the most significant feature and most of these proteins had only very small 
changes in St. Polymerase delta-interacting protein 2 (POLDIP2), which is annotated to both 
the nucleus and mitochondria but for which GO presently has no biological process 
annotation, was of this type and seems to represent a modulator for the POLD-related cluster 
we detected (see Discussion). Several RAB proteins (RAB2, RAB5A, RAB5B) that showed 
only very small changes in St were also included in this class. These might represent vesicle-
mediated transport to/from the nucleus (see below). Fig. 6B indicates that changes in both 
total protein abundance and in subcellular distribution are crucial in achieving the complex 
pattern of changes in compartmental abundances. 
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Finally, a third general characteristic apparent from the data is that the same protein may be 
involved in a variety of different functional processes that in many cases involve different 
subcellular locations. For example, Plasminogen activator inhibitor 1 (SERPINE1) is 
annotated by GO to 10 biological processes ranging over extracellular matrix organization, 
cellular component movement and DNA-templated transcription. Concomitantly the data 
suggests that any given biological process may be altered by changes in the compartmental 
abundance of only a limited number of proteins (Table 2). However, overall enrichment of 
current GO biological process terms was of moderate help in obtaining biologically 
meaningful interpretations of the data. Four proteins in the 121-OxS set lacked biological 
process annotations, much literature information seems not to have been incorporated in 
useful forms in the classifiers and only 82 of the proteins in the 121-OxS set are covered by 
the enriched terms shown in Table 2. Furthermore, the enriched terms also seem to be 
conditioned by the contexts in which these proteins have previously been investigated. For 
example, IMR90 cells do not have phagosomes and the processes “phagosome maturation” 
and “insulin receptor signalling pathway” almost certainly reflects lysosomal/endosomal 
Quantified4
number	
genes
p-value5
number	
genes
p-value5
number	
genes
p-value5 genes
number	
genes
GO:0042776
mitochondrial	ATP	synthesis	
coupled	proton	transport
11 <	1.0E-17 10 1.20E-14 10 <	1.0E-17
ATP5A1,	ATP5B,	ATP5C1,	ATP5D,	ATP5F1,	ATP5H,	ATP5I,	ATP5J,	
ATP5L,	ATP5O
11
GO:0090382 phagosome	maturation 11 3.05E-11 11 9.44E-13 11 7.11E-15
ATP6V0A1,	ATP6V0D1,	ATP6V1A,	ATP6V1B2,	ATP6V1C1,	
ATP6V1D,	ATP6V1E1,	ATP6V1F,	ATP6V1G1,	ATP6V1H,	TCIRG1
16
GO:0033572 transferrin	transport 11 2.71E-10 11 8.72E-12 11 6.83E-14
ATP6V0A1,	ATP6V0D1,	ATP6V1A,	ATP6V1B2,	ATP6V1C1,	
ATP6V1D,	ATP6V1E1,	ATP6V1F,	ATP6V1G1,	ATP6V1H,	TCIRG1
18
GO:0008286
insulin	receptor	signaling	
pathway
13 1.53E-08 12 4.48E-09 11 5.32E-10
ATP6V0A1,	ATP6V0D1,	ATP6V1A,	ATP6V1B2,	ATP6V1C1,	
ATP6V1D,	ATP6V1E1,	ATP6V1F,	ATP6V1G1,	ATP6V1H,	TCIRG1
32
GO:0055085 transmembrane	transport 54 1.95E-10 45 1.56E-10 34 8.40E-10
ABCC4,	ATP5A1,	ATP5B,	ATP5C1,	ATP5D,	ATP5F1,	ATP5H,	ATP5I,	
ATP5J,	ATP5L,	ATP5O,	ATP6V0A1,	ATP6V0D1,	ATP6V1A,	
ATP6V1B2,	ATP6V1C1,	ATP6V1D,	ATP6V1E1,	ATP6V1F,	
ATP6V1G1,	ATP6V1H,	CCT8,	FTH1,	FTL,	HK1,	HMOX1,	HSPA1A,	
HSPA4,	LONP1,	PSMD6,	RPS27A,	SLC39A7,	TCIRG1,	THBS1
313
GO:0051084
'de	novo'	posttranslational	
protein	folding
10 4.69E-06 10 2.58E-07 9 6.00E-08 CCT2,	CCT3,	CCT4,	CCT5,	CCT6A,	CCT7,	CCT8,	HSPH1,	TCP1 30
GO:0022904
respiratory	electron	transport	
chain
15 1.38E-04 12 2.93E-04 12 4.21E-06
ATP5A1,	ATP5B,	ATP5C1,	ATP5D,	ATP5F1,	ATP5H,	ATP5I,	ATP5J,	
ATP5L,	ATP5O,	SDHA,	SDHB
78
GO:0043066
negative	regulation	of	
apoptotic	process
41 1.65E-14 29 6.69E-10 15 1.77E-04
AURKB,	CEBPB,	HMOX1,	HSPA1A,	HSPA9,	POR,	PSMD11,	PSMD5,	
PSMD6,	RPS27A,	SERPINE1,	SET,	SQSTM1,	THBS1,	TIMP1
156
GO:0007264
small	GTPase	mediated	signal	
transduction
19 2.30E-04 15 5.10E-04 9 1.00E-02
FARP1,	HMOX1,	IQGAP1,	KIF14,	RAB2A,	RAB5A,	RAB5B,	RND3,	
SQSTM1
115
GO:0055114 oxidation-reduction	process 28 2.07E-01 22 1.64E-01 20 1.10E-02
ABCC4,	ALDH18A1,	CYB5B,	CYB5R3,	ECH1,	ETHE1,	FTH1,	GPD2,	
HADHA,	HCCS,	HK1,	HMOX1,	IQGAP1,	POR,	PTGS1,	PYCR1,	
RPS27A,	SDHA,	SDHB,	SQRDL
334
GO:0006936 muscle	contraction 6 8.04E-02 5 6.18E-02 5 1.11E-02 CALD1,	CNN1,	MYOF,	TPM3,	TPM4 51
GO:0007155 cell	adhesion 18 9.75E-03 13 2.92E-02 10 1.85E-02
ATP5B,	COL1A1,	KIF14,	LGALS1,	MFGE8,	RND3,	SERPINE1,	TGFBI,	
THBS1,	TPM4
145
GO:0006986 response	to	unfolded	protein 8 3.75E-02 7 2.03E-02 5 2.71E-02 ATP6V0D1,	HSPA1A,	HSPA4,	HSPH1,	THBS1 62
GO:0000209 protein	polyubiquitination 21 2.75E-10 17 4.42E-09 5 3.11E-02 PSMD11,	PSMD5,	PSMD6,	RPS27A,	UBR5 64
Table	2.	Enrichment	of	GO	Biological	Process	Terms
121-OxS3
	1	Full	set	of	121-OxS	nodes	plus	119	suggested	nodes	from	STRING.	
	2
	Set	of	121-OxS	nodes	plus	52	nodes	suggested	by	STRING	that	were	quantified.	
	3	Set	of	121-OxS	nodes.	
	4	Total	number	of	quantified	proteins	annotated	to	the	indicated	process
	5
	hypergeometic	p-values	calculated	relative	to	the	background	of	MS	quantified	proteins.
GO	ID GO	Name
173-OxS2240-OxS1
 29 
processes (see Discussion). There are strong indications for vesicle mediated protein 
transport in the response to TBP treatment (see below) and the term “de novo 
posttranslational protein folding” may be related to the role of the CCT complex in 
sperm/oocyte fusion which involves membrane fusion of a specialized form of a lysosomal 
exocytotic vesicle (acrosome). Similarly “muscle contraction” may be an indication of 
relationships to endocytotic processes. Additional GO terms that cover other 121-OxS 
proteins and biological processes as well as the complete protein identities for the 240-OxS, 
173-OxS, 121-OxS and MS-quantified protein sets are given in Supplementary Table S3.  
3.5. Metabolic and anti-oxidant features related to nuclear respiratory factor 2 and the 
proline regulatory axis  
Nuclear factor-erythroid 2 p45-related factor 2 (NRF2, also called NFE2L2) is a crucial 
transcription factor for many aspects of intrinsic resistance and response to oxidative stress.31 
There are substantial indications for involvement of NRF2 in intermediary metabolism 
including glycolysis, the TCA cycle, generation of NADPH, glutamine metabolism, and fatty 
acid oxidation.31 It translocates to the nucleus in our experiments (Fig. 1) and we therefore 
examined the behaviour in our data of proteins known to be regulated by NRF2. We used a 
recent compilation of genes reportedly subject to positive regulation by NRF2.31  
 30 
NRF2 has been proposed to cause changes in the glycolysis and pentose phosphate pathways 
that generate NADPH used by antioxidant proteins. We monitored numerous proteins in this 
pathway (Fig. 7A). There was little change in abundance for either of the isoforms of 
pyruvate kinase (St = 1.08, 0.99) or in the enzymes G6PD/PGLS/PGD (St = 1.12, 0.94, 1.04) 
in the oxidative arm of the pentose phosphate shunt. The TALDO/TKT arm of the pentose 
phosphate shunt showed modest increases in abundance (St = 1.08, 1.39). However, 
MTHDF2 showed an appreciable decrease (St = 0.58) suggesting that in our experiments 
either input to purine synthesis via the pentose phosphate shunt is not strongly modified, or 
might augment modestly via MTHDF1/MTHDF1L1 (St = 0.96, 0.91). With the exception of 
the C  N translocation of HK1, none of the glycolytic proteins were included in the 121-
OxS set of most significant changes. Although HK1 is totally disconnected in Fig. 6A, 
subcellular translocation of HK1/HK2 is a known effect related to the metabolic fate of 
glucose and to glycolysis in cancer cells.51,70-72 We consider that the behavior observed for 
HK1 represents a prototype for a “selective messenger”, i.e. a single protein displaced to a 
subcellular location distinct from a dense, spatially-defined functional network. In this case, 
as a messenger from glycolysis to the nucleus, HK1 relies almost exclusively on 
redistribution of subcellular location (St = 1.14, Sn = 2.02, Sc = 1.10, log2(Sn/Sc) = 0.87). 
Similar results were obtained for the TCA cycle. For 12 enzymes in the core of this cycle 
(SUCLA2, SUCLG2, FH, MDH2, MDH1, IDH2, IDH3A, IDH3B, IDH3G, CS, ACO2, 
Figure 7. Three selected processes/networks. These dense networks are highly interrelated and 
were extensively quantified in the MS measurements (yellow nodes), but only a small subset of 
the proteins in each network (red nodes) were included in the most significant changes. 
 31 
ACO1) there were only minor changes in total (0.83 < St < 1.11) or compartmental 
abundance (Fig. 7B). Slightly more pronounced decrease in abundance was observed for the 
proteins with lipoamide E cofactor in the TCA cycle (DLD, DLST, OGDH; 0.70 < Sn, St < 
0.76) with indication for moderate N  C redistribution (Supplementary Table S1) and for 
SUCLG1 (St, Sc ~ 0.75). This would be consistent with slightly reduced production of 
succinyl-CoA from 2-oxo-glutarate and its subsequent usage in the TCA cycle. The 
lipoamide E proteins of the pyruvate dehydrogenase complex (DLD, DLAT, PDHB) showed 
a similar moderate decrease in abundance (0.70 < St < 0.85). This would be consistent with 
reduced production of acetyl-CoA from pyruvate. There was a modest decrease in IDH2 (St, 
Sc ~ 0.91) and a modest increase in cytoplasmic IDH1 (St, Sc ~ 1.33). None of these proteins 
were included in the 121-OxS set of most significant changes (Fig. 7B) where the outstanding 
change in the TCA cycle was decrease in SDHA and SDHB (Sn, St ~ 0.37). SDHA and 
SDHB were connected by STRING to ATP synthase (Fig. 6A), presumably as a consequence 
of well-studied mitochondrial interactions. However, there is very little information available 
on possible functional roles for SDHA, SDHB and ATP5 subunits in the nucleus, even 
though SDHA and SDHB are known to be involved in various types of cancers and other 
diseases.73-77 SDHA and SDHB may be selective messengers to the nucleus about 
mitochondrial state. 
NRF2 is thought to play an important role in NADPH homeostasis via regulation of the 
NADPH-generating enzymes G6PD, PGD, IDH1,2 and NADP-dependent malic enzyme 
(ME1), which provides an alternative source of pyruvate by decarboxylation of malate.31 We 
observed a modest increase in abundance for ME1 (St = 1.19). We also observed a modest 
change in mitochondrial NAD(P) transhydrogenase NNT (St = 0.71), which can couple 
production of NAPDH to the mitochondrial hydrogen ion gradient.78 Altogether these results 
suggest that augmented production of NADPH via NRF2/glycolysis/TCA cycle is not a 
major response in our experiments. In keeping with this, we did not observe strong changes 
 32 
in the levels of proteins of glutathione or thioredoxin based anti-oxidant systems. Glutathione 
peroxidases GPX1 and GPX8 (St ~ 0.7), glutaredoxin GLRX3 (St = 1.02), isoforms 1 and 3 of 
glutaminase GLS (St = 0.93, 0.83), and glutathione reductase GSR (St = 1.32) all showed only 
modest changes in abundance. Only small changes in abundance were also observed for 
thioredoxin TXN (St = 1.23), thioredoxin reductases TXNRD1 and TXNRD2 (St = 1.16, 
0.93), and peroxiredoxins PRDX1,2,4,5,6 (0.93 < St < 1.15). Only PRDX3 showed slightly 
different behaviour (St = 0.77, Sn = 0.63, Sc = 0.92). None of these anti-oxidant proteins were 
amongst the 121-OxS set.  
We also monitored 24 proteins annotated to fatty acid oxidation (Supplementary Table S1). 
For 21 of these proteins there was very little change in total (0.82 < St < 1.19) or 
compartmental abundance. Substantial changes in total and nuclear abundance were observed 
for subunits of the mitochondrial trifunctional enzyme HADHA/HADHB (St = 0.65/0.68; Sn 
= 0.61/0.60; Sc = 0.93/0.97). The Electron transfer flavoprotein-ubiquinone oxidoreductase 
ETFDH appeared to show similar behaviour, but with a small number of SILAC ratio counts 
(Supplementary Table S1). We conclude that in our experiments any effects of NRF2 on fatty 
acid oxidation are limited to indirect effects associated with changes in the nuclear abundance 
of HADHA/HADHB and possibly ETFDH. Similarly, many proteins associated with 
detoxification of drugs whose abundance is controlled by NRF2,31 including oxidation of 
drugs (aldehyde dehydrogenases, aldo-keto reductases, carbonyl reductases CBR1 and 
CBR3, epoxide hydrolase EPHX1, prostaglandin reductase PTGR1), conjugation of drugs 
(glutathione S-transferases GSTM3, GSTP1, MGST1) and drug transport (ABCC1) showed 
very little change in abundance. From the many proteins associated with drug detoxification, 
there was one protein with modest changes, Microsomal glutathione S-transferase MGST3 (St 
= 1.33), and one protein that was included in the 121-OxS set, multidrug resistance-
associated protein 4, ABCC4 (St, Sn = 0.50).  
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Finally it has been suggested that NRF2 may regulate glutamine metabolism via glutamine 
synthase (GLS).79 We monitored isoforms 1 and 3 of GLS, which showed only small changes 
in abundance (St = 0.93, 0.83). GLS is also part of a group of proteins termed the “proline 
regulatory axis” (PRA, Fig. 7C) that are intimately connected to redox regulation, 
glutamine/proline metabolism, the urea cycle, the TCA cycle and collagen, and which have 
been proposed to be intimately involved in metabolic processes connected to cancer.80 The 
PRA represents another pathway in which levels of NADH/NADPH may determine response 
and subcellular distribution of proteins.80 We saw strong changes in abundance and 
subcellular distribution for Pyrroline-5-carboxylate reductase (PYCR1), Delta-1-pyrroline-5-
carboxylate synthase (ALDH18A1) and collagen (COL1A1) that led to inclusion of these 
proteins in the 121-OxS set (Fig. 7C). GLS is also involved in the cell cycle81 and we have 
previously identified characteristic, but different changes for proteins of the PRA associated 
with cell cycle arrest at the origin activation checkpoint for DNA replication.21 We therefore 
suggest that the apparent effects of NRF2 on glutamine metabolism may be indirect 
consequences of changes associated with the cell cycle and/or involvement of the proline 
regulatory axis, which has connections to oxidative stress, ROS signalling, p53 and, in the 
present context, anti-proliferative effects.80 
The above results would suggest that metabolic and anti-oxidant activities controlled by 
NRF2 are not a major contributor to the response of IMR90 cells that are preconditioned and 
then challenged with TBP. On the other hand, NRF2 seems to be active at anti-oxidant 
response elements (ARE) since amongst the transcription factors and accessory proteins 
controlled by NRF231 we detected a strong increase in the abundance of the 
CCAAT/enhancer-binding protein beta CEBPB (St, Sn = 2.23) and moderate increases for an 
accessory protein involved in NRF2 transcription MAFG (St = 1.48, but with only 5 SILAC 
ratio counts). This suggests that there may be modularity in the transcriptional activity of 
NRF2. This is also indicated by our results for proteins involved in heme and iron 
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metabolism that are controlled by NRF2. Both subunits of ferritin FTL, FTH1 (St = 1.72, 
1.84) and heme oxygenase HMOX1 (St = 7.11) showed strong increases in abundance, but 
biliverdin reductase (BLVRA) and flavin reductase NADPH (BLVRB) did not (St = 1.03, 
1.00).  
It may be that the features we observe are specific to TBP preconditioning and treatment and 
not necessarily identical to cellular response to other ROS since there is evidence for 
differences in cellular response to TBP and H2O2 
82,83 and we also saw only moderate 
changes in catalase CAT (St = 0.89) and superoxide dismutases SOD1 and SOD2 (St = 1.34, 
0.77). The present experiments suggest that NRF2 is intimately involved in the response to 
TBP, but via processes largely outside its “classic” metabolic, drug detoxification and anti-
oxidant activities. Proteins containing heme/iron as cofactors are important in the response to 
TBP (see below), and it has recently been reported that NRF2 can act as a transcription factor 
for expression of hematopoietic proteins involved in heme metabolism and iron homeostasis 
(see Discussion).84 
3.6. Proteins associated with subcellular localization and transport  
The 121-OxS set included a number of 
proteins associated with various aspects of 
subcellular protein localization and 
transport. We identified 448 proteins in the 
GO BP database with annotation to nuclear 
import/export/localization/maintenance or 
their regulation, of which 160 were quantified in the present study. There were 10 proteins 
with indications of possible changes in nuclear transport, of which 5 satisfied the more 
stringent conditions for inclusion in the 121-OxS set and were used in the network searches 
(Table 3). The GO terms suggest these proteins may be involved in different aspects of 
Sc
SigB	
score
Ratio	
Count
Sn
SigB	
score
Ratio	
Count
St
SigB	
score
Ratio	
Count
CDKN1A 1.90 1.02E-03 3 2.07 1.40E-04 5
COL1A1 0.51 9.26E-06 62 0.63 4.03E-02 50 0.57 1.68E-03 114
G3BP2 0.86 4.97E-01 8 1.45 1.22E-02 48 1.44 3.06E-03 53
HSPA9 1.01 7.31E-01 181 1.64 5.72E-05 476 1.58 2.27E-05 664
JUP 0.23 6.36E-08 5 0.25 3.64E-11 6
KPNA2 0.53 1.18E-05 11 0.69 1.01E-01 62 0.67 2.90E-02 73
RANBP17 0.18 7.10E-19 3
SET 1.65 6.31E-05 57 1.22 3.61E-01 11 1.55 4.03E-04 70
TMEM173 0.54 2.78E-02 3 0.54 3.83E-03 3
UBR5 1.78 1.36E-02 15 1.78 5.47E-04 17
Table	3.	Proteins	Involved	in	Nuclear	
Import/Export/Localization/Maintenance	or	its	Regulation1
1	proteins	with	SigB	<	0.005	and	≥	3	ratio	counts	for	at	least	one	of	Sn,	Sc	or	St.	Bold	gene	
names	satisfied	the	more	stringent	conditions	for	selection	of	the	121-OxS	set.
Cytoplasm Nucleus Total
Gene	
Name
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nucleo-cytoplasmic trafficking. For example, collagen COL1A1 is annotated to “protein 
localization to nucleus” (GO:0034504) and “regulation of canonical Wnt receptor signaling 
pathway” (GO:0060828), whereas karyopherin KPNA2 is annotated to “NLS-bearing 
substrate import into nucleus” (GO:0006607). Although the proteins in Table 3 are involved 
in many cellular processes (Supplementary Table S1), only CDKN1A currently has 
annotation to processes related to oxidative stress (GO:2000377, “regulation of reactive 
oxygen species metabolic process”). Other proteins are best known for very different 
processes, e.g. the involvement of HSPA9 in protein targeting to mitochondria.85-87  
We identified 1175 proteins annotated to 
“vesicle-mediated transport” (GO:0016192) 
and 503 proteins annotated to “cytoplasmic 
vesicle” (GO:0031410) in the GO database. 
These included a significant number of 
common proteins. We therefore looked at 
the set of 1427 proteins that were annotated 
to one or both of these terms, of which 344 
were quantified in the present experiments 
and 100 had annotations to the nucleus. We 
quantified 251 of these proteins in the 
nucleus and 70 were annotated to the 
nucleus. As with other subcellular organelles 
(Fig. 3, Supplementary Figure S2), a large 
majority of these proteins showed little or no 
change in their fraction in the nucleus and 
there was no apparent difference between 
proteins with/without annotation to the 
Figure 8. Analysis of proteins annotated to vesicular 
trafficking. Left: log2(Sn/St) = log2(fs/fu) as a function 
of the average number of ratio counts over the 
nucleus and total data sets for proteins annotated to 
“vesicle-mediated transport” and/or to “cytoplasmic 
vesicle”. Proteins with (red, 70 proteins) or without 
(blue, 181 proteins) annotation to nucleus are 
indicated. Right: number of proteins versus 
log2(fs/fu). Table. Data for 28 proteins of the 121-
OxS set. 
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nucleus (Fig. 8). That is, the data is consistent with trafficking of a specific subset of these 
proteins. Further evidence for selectivity in nucleo-cytoplasmic trafficking of these types of 
proteins is provided by the observation that 29 Ras-related RAB proteins were quantified in 
our experiments and 14 were annotated to vesicle mediated transport, but only 3 showed 
evidence of nucleo-cytoplasmic trafficking following TBP treatment. However, the 121-OxS 
set included 28 such proteins, of which 27 were quantified in the nucleus and 8 are presently 
annotated to the nucleus. Eleven of these proteins showed substantial changes in the fraction 
of the protein in the nucleus (|log2(Sn/St)| = |log2(fs/fu)| > 0.5, Fig. 8), including RAB2A, 
RAB5A and RAB5B. This suggests that vesicle trafficking involving the nucleus is an 
appreciable part of the response to oxidative stress and it is striking that seven of these 
proteins are involved in iron metabolism (ATP6V0A1, ATP6V0D1, ATP6V1C1, ATP6V1H; 
FTL, FTH1, HMOX1). A further 3 proteins involved with iron/heme metabolism are 
currently annotated to the “vesicular fraction” (PGRMC1, POR, PTGS1, see below). It is also 
noteworthy that many of these 28 proteins were only modestly connected by STRING (Fig. 
6A), possibly because such subcellular trafficking is not well represented in the STRING 
database (see Discussion).  
3.7. Indications of extensive involvement of iron/heme metabolism and mitochondria 
Proteins that involve iron homeostasis and/or heme/iron as a cofactor are substantially 
enriched in the 121-OxS set. In the full MS data set, 93 of the 3124 quantified proteins 
involve iron or heme in the GO biological process or GO molecular function terms and the 
121-OxS set includes 20 of these proteins. Of these 20 proteins, 19 were quantified in the 
nucleus, 13 were amongst the most significant changes in Sn and 6 amongst the most 
significant changes for St and/or Sn/Sc. Only 3 of these 19 proteins are currently annotated to 
the nucleus (ATP6V0A1, HMOX1, PGRMC1) and although these three proteins participate 
in a multitude of biological processes (Supplementary Table S2), their functions in the 
nucleus are poorly defined. The proteins not presently annotated to the nucleus include 10 
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subunits of V-type proton ATPase (ATP6) and both ferritin subunits (FTL, FTH1), which are 
known to play important roles in iron homeostasis,88-90 but whose nuclear role(s) are 
ambiguous. Also included are three oxidoreductases (CYB5B, CYB5R3, POR) that 
are/involve heme proteins and the Succinate dehydrogenase [ubiquinone] iron-sulfur subunit 
(SDHB) that relies on an iron-sulfur cluster for its activity. The heme protein Prostaglandin 
G/H synthase 1 (PTGS1) was not quantified in the nucleus, but showed significant decrease 
in abundance in the cytoplasmic compartment. Overall, the present data indicates that 
changes in both abundance and subcellular location of a specific set of proteins related to 
iron/heme metabolism are an important contributor to the cellular response to oxidative 
stress. Somewhat surprisingly, only 4 of the 20 proteins are currently annotated to stress 
responses, only 2 (HMOX1, PTSG1) are annotated to response to oxidative stress and very 
few of the 19 proteins we quantified in the nucleus seem to have annotated functional roles 
there (see Discussion).  
A similar situation appears to exist for mitochondrial proteins. The 121-OxS set includes 41 
proteins annotated to mitochondria, of which 39 were quantified in the nucleus, 25 
corresponded to most significant changes for Sn, 2 (CYB5B, ETHE1) corresponded to most 
significant change for Sc, and 12 corresponded to most significant changes for St and/or Sn/Sc. 
Only 7 of these proteins (ATP5A1, ETHE1, HSPA1A, HSPA9, NME1, POLDIP2, PTRF) 
are currently annotated to the nucleus. Polymerase delta-interacting protein 2 (POLDIP2, 
mitochondrial nucleoid91) and Polymerase I and transcript release factor (PTRF, transcription 
from RNA polymerase I promoter92) potentially have similar roles in both locations and both 
are characterized by moderate increases in total abundance plus C  N redistribution. Of the 
other five proteins, ATP5A1, HSPA1A (co-localization with the COP9 signalosome69), 
NME1 (positive regulation of DNA binding93) and HSPA9 (poly(A) RNA binding94,95; 
protein export from nucleus) presently have weak indications for possible nuclear functions 
in their GO biological process annotations. There seems to be little information on nuclear 
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roles for the other 32 mitochondrial proteins detected in the nucleus, which include 27 
proteins annotated to the mitochondrial matrix/inner membrane: 10 subunits of ATP synthase 
(ATP5), 2 proteins of the TCA cycle (SDHA, SDHB), 2 proteins of the proline regulatory 
axis (ALDH18A1, PYCR1), mitochondrial peptidases (AFG3L2, LONP1, PITRM1, 
PMPCB), other proteins involved in oxidation-reduction processes (CYB5B, CYB5R3, 
GPD2, HADHA, HCCS, POR, SQRDL) as well as LETM1 (a mitochondrial Ca2+ and/or K+ 
transporter96) and PTCD1. There were only a few proteins with clearly defined functions 
outside mitochondria (ATP6V1A, ATP6V1E1, CCT7, ECH1, HK1, HSPA4, POR, TCIRG1). 
Seven of the proteins annotated to mitochondria and detected in the nucleus were common to 
the set of iron/heme proteins described above (ATP6V1A, ATP6V1E1, CYB5B, CYB5R3, 
POR, SDHB, TCIRG1). It is also striking that nine of the proteins in the 121-OxS set 
annotated to mitochondria (ATP5A1, ATP5B, ATP6V1A, ATP6V1E1, CCT7, ECH1, 
HSPA1A, HSPA4, HSPA9) are annotated to the extracellular vesicular exosome and one 
(TCIRG1) to the phagocytic vesicle membrane. Only four of these mitochondrial proteins are 
currently annotated to stress responses (HSPA1A, HSPA4, LONP1, PYCR1). Although 
further confirmatory experiments are clearly necessary, the observation that 39 mitochondrial 
proteins (of the 371 quantified in the nucleus) show such changes suggests that subcellular 
redistribution of specific mitochondrial proteins is also an important characteristic of 
response to oxidative stress. 
4. DISCUSSION 
The proteomics subcellular spatial razor offers a powerful framework to look at dynamic 
changes in protein distribution over defined locations. Our previous results on cell cycle 
arrest in IMR90 cells21,34 and on cellular response to estradiol in breast cancer cells22 as well 
as fluorescence-based results on genome-wide spatial response to hypoxia in yeast19 
emphasize that the subcellular distribution of proteins is highly dynamic and context 
dependent. The present experiments confirm dynamic redistribution of numerous proteins in 
 39 
the context of oxidative stress and suggest that many aspects of cellular response to oxidative 
stress are still incompletely understood. Response to oxidative stress and ROS signalling is 
now known to have many ramifications in a wide variety of cellular processes and we have 
primarily viewed these processes from a nuclear-defined perspective. In this context we 
discuss four topics in the following. (1) The general properties of the proteomics subcellular 
spatial razor, especially the selectivity of the compartmentalized changes in protein 
abundance. (2) An overview of proteins that are known to be involved processes such as cell 
cycle control, autophagy/mitophagy and signalling systems. This overview is not and is not 
meant to be exhaustive. We anticipate that identifying those proteins that are most prominent 
in the nuclear response to TBP-induced oxidative stress (Table 2, Supplementary Table S2, 
S3) will be useful to enthusiasts of these topics. (3) A more detailed analysis of two features 
that seem to be related and to be more novel in current understanding of response to oxidative 
stress: the involvement of proteins involved in heme/iron metabolism or with heme/iron as 
cofactors; and, links to nuclear hormone metabolism/receptors that are involved in cancer. (4) 
Finally, we briefly address the need to begin constructing models of cellular function that 
include functional systems spatially dispersed over different subcellular locations and 
dynamic changes in the subcellular spatial dispersion of proteins.  
4.1. Properties of the Subcellular Spatial Razor.  
A striking general result of the present experiments is that both with and without TBP 
treatment large numbers of proteins are detected in the nucleus that are annotated by GO to 
other subcellular locations. However, in all of the subcellular locations tested (Fig. 3, 
Supplementary Figure S2) only a small subset of the proteins annotated to any given non-
nuclear location respond to oxidative stress via changes in compartmental abundance. These 
changes in compartmental abundance are achieved by a combination of changes in total 
cellular abundance and in subcellular distribution, with redistribution at least equally 
important to changes in total abundance. The strong internal consistency of the results 
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indicates they do not reflect artefacts of the nuclear enrichment and is consistent with results 
gradually being obtained and collated by large numbers of independent experiments by 
others, e.g., that 36% of all human proteins in the GO database are annotated to multiple 
locations. A second line of evidence that indicates reliability is provided by our previous 
nuclear spatial razor experiments on IMR90 cells in the context of cell cycle arrest induced 
by depletion of the CDC7 kinase21 in which nuclear enrichment was achieved with the same 
protocol. Only 14 proteins are common to the 121-OxS set and the set of 124 most significant 
proteins detected following CDC7-depletion. That is, the changes in abundance/distribution 
detected with the spatial razor show high discrimination between different cellular 
stimulations. The TCA cycle, glycolysis and the proline regulatory axis provide instructive 
examples. For glycolysis, the strong increase in HK1 abundance in the nucleus was observed 
only for oxidative stress, but not for cell cycle arrest.21 For the proline regulatory axis (Fig. 
7C), PYCR1 and ALDH18A1 were in the 121-OxS set, but GLS, GLUD1 and OAT showed 
strong changes for CDC7-depletion induced cell cycle arrest21 and collagen (COL1A1) was 
substantially decreased/increased respectively. For the TCA cycle, with oxidative stress we 
detected changes in SDHA and SDHB, whereas for CDC7-depletion induced cell cycle arrest 
changes in ACO2, DLD, FH, IDH2, MDH2 and SUCLG1 were detected in the nucleus.21 
Given that hypoxia also constitutes a form of oxidative stress, it is notable that a genome-
wide scan of subcellular protein distribution in yeast cells in response to hypoxia19 also 
detected redistribution of SDHA. All three of these functional processes further corroborate 
that selective changes characteristic of the cellular stimulation are detected with the spatial 
razor. A third line of evidence for the selectivity/reliability of the subcellular spatial razor as 
applied to the nucleus is provided by direct comparison of the proteome of mitochondria and 
nuclei in MCF7 breast cancer cells, in which nuclei were enriched with similar protocols. We 
have previously shown that in MCF7 cells there are roughly 1000 proteins partitioned to both 
subcellular locations and their partitioning is highly reproducible.23 Stimulation with estrogen 
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results in major nucleo-cytoplasmic redistribution of proteins in MCF7 cells, including over 
100 proteins detected in mitochondria.22 The subcellular redistribution was in fact far more 
prominent than changes in total abundance, which led us to hypothesize that strong 
perturbation of subcellular spatial control may be a characteristic of cancer cells.22 We do not 
see such massive nucleo-cytoplasmic redistribution in IMR90 cells under oxidative stress or 
cell cycle arrest, but it is interesting that estrogen receptor alpha (ESR1) is prominent in the 
240-OxS network (Fig. 6A) and we did detect changes for proteins with direct connections to 
a progesterone receptor in the 121-OxS set (see below).  
Overall, although there is probably room still for technical improvements in the proteomics 
experimental procedures 22  (see also Supplementary Text), there is now strong evidence that 
the nuclear spatial razor provides invaluable information on the role of nucleo-cytoplasmic 
subcellular redistribution in cellular function. An analogous approach should be applicable to 
other subcellular organelles such as mitochondria.  
4.2. An overview of cell cycle control, autophagy/mitophagy, signalling systems and 
mitochondrial response.  
Cell cycle control. Given the substantial evidence for connections between oxidative status 
and the cell cycle,97,98 we were initially surprised to find only a few common proteins 
between our oxidative stress and cell cycle arrest sets of most strongly changed proteins in 
IMR90 cells. Deeper, joint analysis of the two data sets with inclusion of further proteins that 
show pronounced similarities and/or differences between the two responses indicates that 
there are a variety of nuclear processes, including DNA replication, that change in similar 
ways with both oxidative stress and cell cycle arrest. However, these changes are achieved by 
subtle variations in the identity, total abundance and redistribution of multiple proteins 
involved in the process. This joint analysis will be published elsewhere. Here, we give an 
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example for a possibly critical protein, Polymerase delta-interacting protein 2 (POLDIP2), 
whose homozygous deletion is mostly lethal in mice.99 
POLDIP2 has well-studied functional roles involving binding to DNA polymerases and 
mono-ubiquitinated PCNA in the nucleus that seem to involve mechanisms for bypass of 
lesions such as 8-oxo-7,8-dihydroguanine during DNA replication.100-102 It has also been 
reported to be involved in mitotic spindles and chromatin segregation.103 Very recently it has 
been shown that POLDIP2 is involved in the spliceosome and is required for alternative 
splicing of MDM2 in response to UV irradiation, possibly as a consequence of ROS 
signaling.104 This could provide connections to p53,105 p53-induced transcription of 
HMOX1106 and heme interactions with p53.107 Plasma membrane interactions with the 
homophilic cell-cell adhesion receptor CEACAM1 that result in nuclear import of POLDIP2 
in coordination with quiescence/proliferation/cell cycle have also been studied.108 At the 
same time POLDIP2 has other roles in interactions with the ROS-generating protein NADPH 
oxidase 4 (NOX4) in focal adhesions and stress fibers that are involved in ROS signaling, 
extracellular matrix composition and vascular structure and function in mice, apparently by 
reductions in the generation of H2O2 and increased collagen secretion.
99,109  
We observed a substantial increase in nuclear abundance for POLDIP2 (Sn = 1.79) that is 
achieved by a combination of increased total abundance and C → N redistribution (St = 1.67, 
log2(Sn/Sc) = 1.18) and results in a moderate decrease in cytoplasmic abundance (Sc = 0.79). 
In our joint analysis with CDC7-depletion induced cell cycle arrest, the nexus to DNA 
replication is POLD, PCNA and the replication factor C complex, all of which are included in 
the 240-OxS set (Fig. 6A, Supplementary Table S3). Although there are ambiguities about 
the relative amounts of POLDIP2 in different subcellular locations,108 POLDIP2 has also 
been reported to have a mitochondrial targeting sequence, to be primarily in the mitochondria 
of some cell types110,111 and to associate with TFAM and LONP1 in the mitochondrial 
nucleoid.110 Potentially POLDIP2 may be a link between DNA metabolism in the nucleus 
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and mitochondria that is connected to ROS signaling systems. Interestingly, the POLDIP2 
gene is part of a complex sense-antisense architecture that has been associated with ERBB2 
and breast cancer.112  
The NRF2 and FOXO signalling systems. NRF2-related signalling is crucial to response to 
oxidative stress9,31,113 and is clearly engaged in our experiments (Fig. 1). The influence of 
NRF2 on glycolysis, the TCA cycle, NADPH generation and anti-oxidant systems seems not 
to be a major response in our experiments, but NRF2 is clearly active at anti-oxidant response 
elements (upregulation of CEBPB, MAGF) and heme/iron proteins under NRF2 
transcriptional control (HMOX1, FTL, FTH) are amongst the strongest changes in total 
protein abundance. Connections from NRF2 signalling to p53 and cell cycle processes are 
thought to involve FOXO transcription factors.36,114,115 FOXO3 has recently been shown to be 
intimately involved in mitochondrial ROS signalling and apoptotic pathways.116 We 
quantified 296 proteins annotated to apoptosis and 12 were included in the 121-OxS set 
(Table 2). However, these proteins were roughly equally divided between anti-apoptosis 
(SERPINE1, HSPA1A, HMOX1, HSPA9, POR), apoptosis (LGALS1, PSMD6, PSMD5, 
NME1, PSMD11) or both (RPS27A, SQSMT1). A similar mixed pattern between positive or 
negative regulation of apoptosis was found and there were no clear patterns of changes in 
total or compartmental abundances that differentiated between apoptosis/anti-apoptosis. We 
also monitored 28 proteins annotated to caspase activity (GO:0004197) or regulation of 
cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281) of which 
only Thrombospondin-1 (THBS1) was included in the 121-OxS set. Overall, all of these 
proteins have numerous other activities (Supplementary Tables S1, S3) and the data is 
consistent with a modular response to TBP that does not include FOXO3-mediated 
connections to apoptosis. This is consistent with no perceptible increase in dead cells and 
only very small changes in Annexin A5 (St = 1.09). Our data suggested modularity in the 
NRF2-related response to TBP and other interactions involving NRF2, especially 
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transcription of hematopoietic proteins and interaction with SQSMT1 (see below), may be 
crucial. 
Autophagy and Sequestosome-1 (p62/SQSMT1). Our experiments quantified 10 proteins that 
are currently annotated by GO to autophagy, including PARK7, FIS1, NPC1 and 
GABARAPL2 (Supplementary Table S1). The only protein with a GO annotation to 
autophagy in the 121-OxS set is p62/SQSMT1, which has been reported to be important in 
the autophagy response to oxidative damage117 and in huntingtin-induced cell death.118 Other 
studies suggest SQSMT1, together with Parkin, is involved in clustering of mitochondria in 
the perinuclear region,119 but not in mitophagy.120 This is a protein for which apparently 
constitutive, rapid, nuclear-cytoplasmic trafficking via NLS import/export sequences under 
phosphorylation control has been established.121 A direct connection to oxidative stress is 
apparent in the binding of SQSMT1 to KEAP1 with concomitant release of NRF2 and 
creation of a feedback loop by transcription of SQSMT1.122,123 Under stress SQSMT1 has 
been shown to participate in the formation of protein aggregates in the perinuclear region that 
are degraded by selective autophagy.124,125 Such protein aggregates do not seem adequate to 
explain the dynamic nucleo-cytoplasmic distributions that we observe. For example, we 
detected 371 mitochondrial proteins in the nucleus in unstimulated cells, but only 41 are 
included in the 121-OxS set. There are both increases and decreases in nuclear abundance for 
the 39 mitochondrial proteins in the 121-OxS set quantified in both cellular compartments 
and many of these proteins show redistribution between the nuclear and cytoplasmic 
compartments with little or no change in total abundance (Fig. 3, Supplementary Table S2). 
We suspect that in addition to its roles in aggregation of damaged proteins SQSMT1 might 
have other roles in nucleo-cytoplasmic trafficking of (ubiquitinated) proteins, e.g. of PCNA, 
which binds both POLDIP2 and Flap endonuclease 1 (FEN1).126 Like many proteins 
associated with autophagy,127 SQSMT1 is involved in other processes (Table 2) and in our 
experiments it seems to be more directly associated with changes related to cancer and 
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interactions with mTOR in lysosomes128 (see below). It may also be noted that clustering of 
mitochondria in the perinuclear region is not unique to autophagy since such clustering has 
been reported to produce an oxidant rich nuclear domain that is required for hypoxia-induced 
transcription.129 Furthermore, it has been reported that some conditions that favour mitophagy 
result in movement of mitochondria towards lysosomes.130  
The 121-OxS set does include one further protein that has very recently been associated with 
autophagy (PGRMC1, see below), but in general our experiments seem to show limited direct 
connection to autophagy/mitophagy, with stronger indications for other processes (see 
below). As has been noted in the context of long-lived neuronal cells,131 the urgency attached 
to identifying disease-related processes may be emphasizing research into pathological 
extremes and obscuring the need to elucidate basic, underlying mechanisms of inter-organelle 
trafficking and degradatory turnover of proteins in normal cellular function.  
Mitochondria and the retrograde response. Because our experiments concentrate on the 
nucleus, they only indirectly bear on mitochondrial processes. However, the observation that 
of the 121 proteins showing the most significant changes, 39 proteins detected in the nucleus 
are annotated to mitochondria is consistent with extensive retrograde signalling from 
mitochondria to the nucleus in response to TBP-induced oxidative stress. Retrograde 
mitochondria to nucleus signalling is vital in many cellular processes and contexts.132  
Detailed interpretation of our results is complicated by the fact that of these 39 mitochondrial 
proteins only a handful has known functions in the nucleus. For example, there has recently 
been considerable interest in KIAA1967 (also known as Deleted-in-breast-cancer-1, DBC1) 
in the context of cancer mechanisms. While there is still discussion of whether KIAA1967 is 
really deleted/involved in cancer,133 clear evidence has been obtained for diverse functional 
roles in the nucleus including as a regulator of histone deacetylase chromatin remodeling 
enzymes and transcription factors134 as well as in alternative mRNA splicing.135 These 
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include direct interactions with several nuclear receptors including estrogen receptors  and 
136,137 Interestingly, KIAA1967 (DBC1) has been detected in mitochondria.138 We observed 
substantial changes for KIAA1967 (moderate change in Sn and St ~ 1.25, Sc = 0.5, C → N 
redistribution with log2(Sn/Sc) = 1.3) in response to oxidative stress. It is tempting to speculate 
that KIAA1967 might also have mitochondrial functions related to oxidative stress, perhaps 
in connection with the metabolic changes associated with the presence of estrogen receptors 
and other nuclear hormone receptors in mitochondria.139  
Conversely, we detected proteins in the nucleus that have defined function(s) in 
mitochondria, but seem not to have established functions in the nucleus. For example, Lon 
protease (LONP1) is annotated to the mitochondrial nucleoid and has well-studied roles in 
proteolytic clearance of damaged proteins. Under acute stress within the mitochondrial 
matrix, Lon works as a protector protein in the degradation of oxidized proteins, while under 
chronic conditions the level of Lon declines and this function is lost.140 Lon can also act as a 
chaperone,141 attaches to promoter sequences in mDNA and to genomically important 
proteins such as mitochondrial transcription factors,142,143 and has been reported to bind to 
POLDIP2 in the mitochondrial nucleoid.110 We detected appreciable nuclear changes for 
LONP1 (Sc = 1.17, Sn = 0.55, St = 0.67, N → C redistribution with log2(Sn/Sc) = -1.08) that 
suggest LONP1 might also have nuclear functions that are modulated by oxidative stress.  
We detected many other mitochondrial proteins in the nucleus with tantalizing changes in 
response to oxidative stress. These are suggestive of extensive retrograde mitochondrial to 
nucleus signalling that might involve variable, dynamic partitioning of proteins between the 
nucleus and mitochondria. A prototype for this type of retrograde control is C. elegans 
ATFS-1 (activating transcription factor associated with stress-1), which senses mitochondrial 
stress and communicates with the nucleus during the mitochondrial unfolded protein 
response. Constitutively synthesized ATFS-1 is normally imported to mitochondria and 
degraded, but under stress changes in nuclear/mitochondrial distribution are caused by 
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reduced mitochondrial import.144 In this context we note that the 121-OxS set contains 
several proteins associated with mitochondrial import processes (HSPA9, PITRM1, 
PMPCB). NRF2 complexed with KEAP1 may be at least in part a similar retrograde system 
since the complex has been reported to tether to the mitochondrial outer membrane via 
interactions with PGAM5, placing it in proximity to sources of ROS from the respiratory 
chain.145  
4.3. Heme/iron metabolism. 
The above examples corroborate that we detect many proteins with established connections 
to oxidative stress, signalling systems and mitochondria. The information on dynamic spatial 
distribution is largely new and for many of these proteins clarification of possible nuclear 
functions is now desirable. In fact, our results suggest that many other subcellular locations 
besides mitochondria also have protein signalling to the nucleus under oxidative stress and 
may involve more novel systems. Iron metabolism is clearly associated with oxidative stress 
and has also been implicated in many diseases such as type 2 diabetes and obesity,146 
Alzheimer’s and Parkinson’s diseases.147 It has long been known that iron metabolism is 
intimately connected to cancer,148-150 to the extent that iron chelators have been used in 
cancer treatment.151 Subcellular trafficking of proteins involved in iron homeostasis is clearly 
established for systems such as the transferrin cycle.152,153 In our experiments, 93/3569 
proteins are currently annotated to heme/iron and 20 of these were included amongst the 121 
proteins with the most significant changes. A striking feature is that while these proteins are 
annotated to many subcellular locations (10 to plasma membrane, 7 to mitochondria, 9 to 
lysosome, 5 to endoplasmic reticulum, 1 to Golgi apparatus and 4 to endosome) only 4 are 
currently annotated to the nucleus. In response to TBP treatment Cytochrome b5 type B 
(CYB5B) and NADH-cytochrome b5 reductase 3 (CYBR3), which are part of the 
mitochondrial outer membrane, both show moderate increases in abundance in the 
cytoplasmic compartment (Sc = 1.58/1.18, respectively) that is achieved by strong N → C 
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redistribution that overweighs an appreciable decrease in total abundance (St ~ 0.65), i.e. both 
show substantially reduced abundance in the nucleus (Sn = 0.43/0.61 respectively). Ferritin 
heavy/light chains (FTL and FTH1) as well as hemoxygenase (HMOX1) show 2-7 fold 
increases in total abundance that seem to be largely equilibrated over the two subcellular 
compartments within the 4 hours following the TBP challenge. V-type ATP synthase, for 
which we observed increased abundance (St ~ 1.8) and moderate C → N redistribution for 
many subunits (Fig. 4), is involved in iron homeostasis by working to provide acidic 
conditions for iron metabolism within lysosomes and endosomes.154 PGRMC1 is a heme-
containing protein with connections to both sterol receptors and autophagy (see below). The 
other outstanding feature of the group of iron/heme related proteins is that many are involved 
in vesicle-mediated subcellular trafficking and/or present in the extracellular vesicular 
exosome. In short, the present experiments provide strong evidence for an important role of 
trafficking of iron/heme proteins in the response to oxidative stress. More detailed 
interpretation of our results is complicated by the fact that many aspects of the subcellular 
trafficking of iron/heme and of proteins containing these cofactors remains ambiguous in 
both yeast155 and higher eukaryotes.156  
At the same time evidence is accumulating that mitochondria are highly dynamic organelles 
that export proteins by vesicular trafficking to at least peroxisomes and lysosomes in what 
may be constitutive processes.157,158 Under acute oxidative stress mitochondria localize near 
to the nucleus and fragment, leading to the damage-control process of mitoptosis in which 
many mitochondrial proteins appear in the vesicular exosome.159,160 These include a variety 
of proteins for which we detected changes in nuclear abundance. Recently evidence has been 
presented that in aging cells mitochondrial cristae vesicularize and mitochondria may bud 
vesicles containing ATP synthase.161 One of the mitochondrial proteins in the 121-OxS set 
(LETM1) is involved in the formation of mitochondrial christae.. Similarly, in mammalian 
cells it has recently been reported that reduced expression of subunits thought to be essential 
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for oligomerization of ATP synthase dimers results in fission and altered organization of 
mitochondria.162 This is particularly intriguing because it has recently been proposed that 
dimers of ATP synthase distinct from those in cristae constitute the mitochondrial 
permeability transition pore163,164 and TBP has been reported to lead to mitochondrial 
depolarization.165,166 This might provide mechanisms related to our observation of changes in 
nuclear abundance of many ATP synthase subunits. The occurrence of cyclic ROS bursts in 
mitochondria167-169 suggests that there may be mechanisms for such processes in normal 
physiology and not only under stress. Similarly, evidence has recently been obtained that 
under oxidative stress mitochondrial proteins can be transferred to lysosomes by vesicle 
mediated transport that is independent of mitophagy.170  
In short, based on the present experiments and a body of suggestive literature evidence, the 
simplest interpretation of this part of our data would seem to be that vesicular trafficking 
occurs more widely in higher eukaryotic cells than is presently appreciated, which would be 
consistent with GO annotation of 1427 proteins to “vesicle-mediated transport” and/or to 
“cytoplasmic vesicle”. The present data suggests this involves the nucleus and mitochondria 
in addition to other subcellular organelles, and that heme/iron proteins are included in such 
vesicular trafficking. Whatever the mechanism(s) for trafficking of iron/heme proteins, based 
on the present experiments we suggest three possibilities for further investigation of the 
possible role of proteins involved in iron/heme metabolism in subcellular trafficking in 
response to oxidative stress.  
First, subcellular trafficking of the membrane-associated progesterone receptor (MAPR) 
family (PGRMC1, PGRMC2, neudesin, neuferricin) of cytochrome-b-related, heme-
containing proteins171 could be investigated. The prototype of this family is PGRMC1. We 
observed strong N → C redistribution (log2(Sn/Sc) = -1.17) and no change in total abundance 
(St = 0.99) that results in strong decrease in nuclear abundance (Sn = 0.54) and moderate 
increase in cytoplasmic abundance (Sc = 1.22). PGRMC1 has been extensively studied as part 
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of a plasma membrane receptor for progesterone that acts independently of the classical 
progesterone nuclear hormone receptor, including in neuronal cells.172,173 It has recently been 
proposed to be part of a protein complex containing the binding site for the somewhat 
enigmatic sigma-2-recptor that regulates lipid metabolism and hormone signaling and is a 
validated biomarker for tumor cell proliferation.174 There is substantial evidence for 
important roles of both the sigma-2-recptor and PGRMC1 in cancer.174 While much of the 
investigation of PGRMC1 has concentrated on its roles as a progesterone receptor in the 
plasma membrane, it has also been detected in the ER and mitochondria,174 the cellular 
vesicular fraction,175 in the perinuclear region and in the nucleus,176,177 where it has been 
reported to regulate genes associated with inhibition of apoptosis by progesterone.177,178 Very 
recently PGRMC1 was shown to promote autophagy179 and evidence has been presented that 
PGRMC1 may be an adaptor protein for membrane receptors beyond the progesterone 
receptor.180 There is some evidence that location of PGRMC1 to cytoplasmic vesicles is 
related to its carcinogenic activities.175,181-183 Finally, interaction of PGRMC1 with 
plasminogen activator inhibitor 1 RNA-binding protein (PAIRBP1) in nuclear transcriptional 
functions184 and co-localization with aurora kinase b (AURKB) at chromatin in oocyte 
maturation processes185 have been reported. Our 121-OxS set includes AURKB and 
Plasminogen activator inhibitor 1 (SERPINE1). Overall the present results suggest intimate 
connections between oxidative stress and diverse PGRMC1 functions and PGRMC1 
potentially has redox capacity that might be crucial to its multitude of functions. As a heme-
containing protein with multiple known subcellular locations, interactions and functions, 
PGRMC1 seems an excellent candidate for further elucidation of possible connections 
between heme protein trafficking and oxidative stress. We also detected that Cytochrome b5 
type B (CYB5B) and its partner NADH-cytochrome b5 reductase 3 (CYB5R3), which are 
mitochondrial outer membrane proteins, exhibited pronounced N → C redistribution and 
these proteins might also be useful in such studies.  
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Second, subcellular trafficking of NADPH oxidase 4 (NOX4) might be studied. POLDIP2 
and NOX4 can dynamically co-localize to the nucleus in a process that apparently involves 
H2O2 and produces collagen secretion.
109 Although our experiments did not quantify NOX4, 
we did observe an increase in nuclear POLDIP2 and a reduction in cellular collagen 
(COL1A1) that may be mediated via the proline regulatory axis (Fig. 7C). NOX4 has also 
been detected in the endoplasmic reticulum,186 specialized plasma membrane subcellular 
domains such as focal adhesions187 and invadopodia,188,189 as well as mitochondria.190-192 
NOX4 generates ROS in diverse subcellular locations including the nucleus,193,194 
endoplasmic reticulum195 and mitochondria.190,196 NOX4, and other NOX proteins, are 
associated with a wide diversity of cellular functions and diseases that include cancer, 
diabetic kidney disease, cardiovascular disease, Alzheimer’s disease, fibrosis and 
atherosclerosis (for reviews see:15,16,197,198). NOX4 is an integral membrane protein with six 
transmembrane helices containing two heme groups16 and its catalytic function is the transfer 
of electrons from NADPH across biological membranes to molecular oxygen. At present 
there seems to be limited information on how NOX4 partitions to such diverse subcellular 
locations. As an integral membrane protein it is unlikely to reach the nucleus by 
import/export involving the nuclear pore and it seems likely that vesicular trafficking of some 
kind is involved.  
Third, further assessment of the possibility of vesicle trafficking in iron homeostasis might be 
provided by further studies of the subcellular trafficking of the V-type ATPases (ATP6). The 
best studied functional roles for V-type ATPases involve the regulation of the pH of the 
cytoplasm and acidic organelles,154,199 which protects the cell against defects such as iron 
misregulation and oxidative stress that appear if pH homeostasis is lost.200 V-type ATPases 
keep an acidic environment in endosomes and lysosomes which prevents cellular damage 
caused by interaction of iron with hydrogen peroxide.201 Recently it has been reported that 
SQSMT1 interacts with V-type ATPase in lysosomes to activate the rapamycin mTOR 
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pathway involved in cell growth and autophagy,202 senescence and amino acid metabolism.203 
V-type ATPases also influence the insulin receptor signaling pathway: insulin is dissociated 
from its receptor by the acidic environment maintained in endosomes by V-type ATPase.204 
We observed this pathway (Table 2). However, our experiments quantified 21 other proteins 
involved in the insulin receptor pathway that did not show significant changes in total or 
compartmental abundance, suggesting that we may have primarily detected consequences of 
changes in the acidification/depolarization of endosomes/lysosomes. In this context it is also 
interesting that endosomes and lysosomes show cyclic bursts of pH that depolarize these 
subcellular compartments154,201 and might provide normal physiological mechanisms for 
shedding of V-type ATPases. Various subunits of V-type ATPase are currently annotated by 
GO to mitochondria, the plasma membrane, endosomes, lysosomes, the Golgi apparatus, 
vacuoles, the nucleus and cytoplasmic vesicles. V-type ATPases are known to be involved in 
vesicle trafficking199,205,206 and ATP6V0C has recently been reported to regulate the 
metabolism of autophagy proteins involved in age-related neurodegeneration.207 
Interestingly, the 121-OxS set also included renin receptor (ATP6AP2, St = 1.59, Sn = 1.71), 
which is known to interact with V-type ATPases in Wnt/-catenin signaling and also has 
(disputed) connections to the renin–angiotensin hormonal system and various other signaling 
systems.208 Overall there seem to be numerous indications for involvement of subunits of V-
type ATPases in a variety of processes/locations beyond those so far well studied – transfer to 
the nucleus under oxidative stress adds to the possibilities.  
4.4. Conclusions  
The present experiments contain extensive evidence that numerous proteins involved in cell 
cycle control, mitochondrial function, iron metabolism, signaling systems and other 
functional processes show substantial changes in nuclear-cytoplasmic compartmental 
abundance in response to oxidative stress. These changes involve many proteins that are also 
present in diverse non-nuclear subcellular locations. A protein can only exert a function in the 
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locations where it exists and our results suggest that nucleo-cytoplasmic redistribution is at 
least equally important to changes in total protein abundance in achieving the appropriate 
changes in compartmental abundance. Changes in total protein abundance alone are 
inadequate to obtain a comprehensive picture of response to TBP. Similar characteristics 
have been observed for cell cycle arrest at the origin activation checkpoint for DNA 
replication21 and for response to hypoxia.19 Especially pronounced nucleo-cytoplasmic 
trafficking of proteins has been observed in the response of breast cancer cells to estrogen 
simulation.22 There seems to be still much to be learned about the mechanisms that govern 
dynamic partitioning of proteins to different subcellular locations and many proteins for 
which their nuclear roles need to be investigated. A total of 115 proteins in the 121-OxS set 
were quantified in the nucleus, but only 45 of these proteins currently have GO annotations to 
the nucleus. That is, we detected 80 proteins whose possible nuclear functions are presently 
uncertain. Of the 63 proteins detected as having highly significant changes in Sn, there are 40 
that are not currently annotated to the nucleus. These proteins are implicated in many 
functional processes (Table 2, Supplementary Table S2) and the present results provide many 
interesting entry points in the context of oxidative stress. The development of heme was an 
ancient, crucial step in eukaryotic evolution209 and it should not be surprising to find 
iron/heme intimately connected to response to oxidative stress. Similarly, RAB proteins and 
kinesins are intimately involved in many kinds of vesicular trafficking and our observation of 
very selective changes for proteins of these types (RAB2A, RAB5A, RAB5B, KIF14, 
KIF20A) is a strong indication for a role of vesicular trafficking with the nucleus in response 
to TBP treatment.  
More generally, it seems that correlated, dynamic, but very selective changes in the local 
abundance at diverse subcellular locations of substantial numbers of proteins is critical to 
cellular function, that we should begin to think of cellular function in terms of higher level 
processes spatially distributed over different subcellular locations and that we need to 
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construct models of cellular function that explicitly take this into account. So far, apart from 
cancer cells, the proportion of total proteins that redistribute in response to a specific cellular 
perturbation seems to be small (2-5%) and the inclusion of spatial location as an explicit 
factor in models and databases should provide powerful ways to make sense of what may 
otherwise seem a bewildering array of interactions.  
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